10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2019

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                     to                    

Commission file number: 001-35637

ASTA FUNDING, INC.

(Exact name of registrant as specified in its charter)

Delaware	22-3388607
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
210 Sylvan Ave., Englewood Cliffs, New Jersey	07632
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number: (201) 567-5648

Former name, former address and former fiscal year, if changed since last report: N/A

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.01 per share	ASFI	Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒   No   ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    

Yes   ☒     No   ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes   ☐     No   ☒ 

As of February 18, 2020, the registrant had 6,567,765 common shares outstanding.

ASTA FUNDING, INC. AND SUBSIDIARIES

INDEX TO FORM 10-Q

Part I-FINANCIAL INFORMATION	3
Item 1. Condensed Consolidated Financial Statements	3
Condensed Consolidated Balance Sheets as of December 31, 2019 (unaudited) and September 30, 2019	3
Condensed Consolidated Statements of Operations for the three months ended December 31, 2019 (unaudited) and 2018 (unaudited)	4
Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended December 31, 2019 (unaudited) and 2018 (unaudited)	5
Condensed Consolidated Statements of Stockholders’ Equity for the three months ended December 31, 2019 (unaudited) and 2018 (unaudited)	6
Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2019 (unaudited) and 2018 (unaudited)	7
Notes to Condensed Consolidated Financial Statements (unaudited)	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 4. Controls and Procedures	31
Part II-OTHER INFORMATION	33
Item 1. Legal Proceedings	33
Item 1A. Risk Factors	33
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3. Defaults Upon Senior Securities	33
Item 4. Mine Safety Disclosures	33
Item 5. Other Information	33
Item 6. Exhibits	33
Signatures	34

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

ASTA FUNDING, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

	December 31, 2019 (Unaudited)			September 30, 2019
ASSETS
Cash and cash equivalents	$	3,156,000		$	4,308,000
Available-for-sale debt securities (at fair value)		60,587,000			56,123,000
Investments in equity securities (at fair value)		8,234,000			8,136,000
Consumer receivables acquired for liquidation (at cost)		1,448,000			1,668,000
Investment in personal injury claims, net		4,533,000			5,190,000
Due from third party collection agencies and attorneys		421,000			596,000
Accounts receivable, net		203,000			266,000
Prepaid and income taxes receivable, net		68,000			264,000
Furniture and equipment, net of accumulated depreciation of $1.9 million at December 31, 2019 and at September 30, 2019		96,000			120,000
Right of use assets		545,000			–
Equity method investment		278,000			280,000
Settlement receivable		1,095,000			1,558,000
Deferred income taxes		9,457,000			9,631,000
Goodwill		1,410,000			1,410,000
Other assets		978,000			1,135,000
Total assets	$	92,509,000		$	90,685,000
LIABILITIES
Accounts payable and accrued expenses	$	1,027,000		$	941,000
Right of use liability		540,000			–
Income taxes payable		778,000			575,000
		2,345,000			1,516,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock, $.01 par value; authorized 5,000,000 shares; issued and outstanding - none		–			–
Preferred stock, Series A Junior Participating, $.01 par value; authorized 30,000 shares; issued and outstanding - none		–			–
Common stock, $.01 par value, authorized 30,000,000 shares; issued 13,459,708 at December 31, 2019 and September 30, 2019; and outstanding 6,567,765 at December 31, 2019 and September 30, 2019		135,000			135,000
Additional paid-in capital		68,558,000			68,558,000
Retained earnings		89,217,000			88,172,000
Accumulated other comprehensive income, net of taxes		226,000			276,000
Treasury stock (at cost) 6,891,943 shares at December 31, 2019 and September 30, 2019		(67,972,000	)		(67,972,000	)
Total stockholders’ equity		90,164,000			89,169,000
Total liabilities and stockholders’ equity	$	92,509,000		$	90,685,000

See accompanying notes to condensed consolidated financial statements

3

ASTA FUNDING, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended December 31, 2019		Three Months Ended December 31, 2018
Revenues:
Finance income, net	$	3,132,000	$	3,494,000
Personal injury claims income		376,000		713,000
Disability fee income		808,000		1,261,000
Total revenues		4,316,000		5,468,000
Other Income:
Interest and dividend income		329,000		199,000
Other income, net		11,000		35,000
Total other income		340,000		234,000
		4,656,000		5,702,000
Expenses:
General and administrative		3,192,000		3,926,000
Impairment of consumer receivables acquired for liquidation		23,000		–
Loss from equity method investment		4,000		30,000
		3,219,000		3,956,000
Income before income tax		1,437,000		1,746,000
Income tax expense		392,000		471,000
Net income	$	1,045,000	$	1,275,000
Net income per share:
Basic	$	0.16	$	0.19
Diluted	$	0.16	$	0.19
Weighted average number of common shares outstanding:
Basic		6,567,765		6,685,415
Diluted		6,636,098		6,685,722

See accompanying notes to condensed consolidated financial statements

4

ASTA FUNDING, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Loss)

December 31, 2019 and 2018

(Unaudited)

	Three Months Ended December 31, 2019			Three Months Ended December 31, 2018
Comprehensive income is as follows:
Net income	$	1,045,000		$	1,275,000
Net unrealized (loss) gain on debt securities, net of tax benefit / (expense) of $50,000 and ($52,000) during the three months ended December 31, 2019 and 2018, respectively.		(128,000	)		135,000
Reclassification adjustment for securities sold, net of tax expense of $48,000 and $0 during the three months ended December 31, 2019 and 2018, respectively.		122,000			–
Foreign currency translation, net of tax benefit / (expense) of $13,000 and ($25,000) during the three months ended December 31, 2019 and 2018, respectively.		(44,000	)		80,000
Other comprehensive (loss) income		(50,000	)		215,000
Total comprehensive income	$	995,000		$	1,490,000

See accompanying notes to condensed consolidated financial statements

5

ASTA FUNDING, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

	Common Stock				Additional				Accumulated Other						Total
	Issued Shares		Amount		Paid-in Capital		Retained Earnings		Comprehensive Income			Treasury Stock			Stockholders’ Equity
Balance, September 30, 2019		13,459,708	$	135,000	$	68,558,000	$	88,172,000	$	276,000		$	(67,972,000	)	$	89,169,000
Net income		–		–		–		1,045,000		–			–			1,045,000
Unrealized loss on debt securities, net		–		–		–		–		(128,000	)		–			(128,000	)
Amount reclassified from other comprehensive income		–		–		–		–		122,000			–			122,000
Foreign currency translation, net		–		–		–		–		(44,000	)		–			(44,000	)
Balance, December 31, 2019		13,459,708	$	135,000	$	68,558,000	$	89,217,000	$	226,000		$	(67,972,000	)	$	90,164,000

	Common Stock				Additional					Accumulated Other					Total
	Issued Shares		Amount		Paid-in Capital		Retained Earnings			Comprehensive Income		Treasury Stock			Stockholders’ Equity
Balance, September 30, 2018		13,459,708	$	135,000	$	68,551,000	$	80,834,000		$	35,000	$	(67,128,000	)	$	82,427,000
Cumulative effect of adjustment for adoption of ASC 606, net of tax of $80,000		—		—		—		173,000			—		—			173,000
Cumulative effect of adjustment for adoption of ASU No. 2016-01, net of tax of $5,000		—		—		—		(10,000	)		10,000		—			—
Adjusted opening equity		13,459,708	$	135,000	$	68,551,000	$	80,997,000		$	45,000	$	(67,128,000	)	$	82,600,000
Stock based compensation expense		—		—		7,000		—			—		—			7,000
Net income		—		—		—		1,275,000			—		—			1,275,000
Unrealized gain on debt securities, net		—		—		—		—			135,000		—			135,000
Foreign currency translation, net		—		—		—		—			80,000		—			80,000
Balance, December 31, 2018		13,459,708	$	135,000	$	68,558,000	$	82,272,000		$	260,000	$	(67,128,000	)	$	84,097,000

See accompanying notes to condensed consolidated financial statements

6

ASTA FUNDING, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Three Months Ended
	December 31, 2019			December 31, 2018
Cash flows from operating activities:
Net income	$	1,045,000		$	1,275,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		24,000			16,000
Deferred income taxes		176,000			162,000
Impairment of consumer receivables acquired for liquidation		23,000			–
Stock based compensation		–			7,000
Unrealized gain on equity securities		(10,000	)		29,000
Provision/ (recoveries) for bad debts - personal injury claims		(302,000	)		203,000
Loss from equity method investment		4,000			30,000
Changes in:
Prepaid and income taxes receivable		196,000			414,000
Due from third party collection agencies and attorneys		191,000			64,000
Accounts receivable		63,000			(203,000	)
Other assets		156,000			184,000
Other liabilities		43,000			(232,000	)
Right of use assets		91,000			–
Right of use liabilities		(96,000	)		–
Income taxes payable		203,000			–
Net cash provided by operating activities		1,807,000			1,949,000
Cash flows from investing activities:
Principal collected on receivables acquired for liquidation		242,000			535,000
Purchase of available for sale debt securities and investments in equity securities		(48,172,000	)		(25,920,000	)
Proceeds from sale of available for sale debt securities		43,612,000			20,574,000
Proceeds from note receivable		––			482,000
Proceeds from settlement receivable		463,000			473,000
Personal injury claims - advances		(49,000	)		––
Personal injury claims - receipts		1,008,000			1,729,000
Change in equity method investment		(2,000	)		(61,000	)
Net cash used in investing activities		(2,898,000	)		(2,188,000	)
Cash flows from financing activities:
Net cash provided by financing activities		––			––
Foreign currency effect on cash		(61,000	)		166,000
Net decrease in cash and cash equivalents		(1,152,000	)		(73,000	)
Cash and cash equivalents at beginning of period		4,308,000			6,284,000
Cash and cash equivalents at end of period	$	3,156,000		$	6,211,000
Supplemental disclosure of non-cash operating activities:
Initial recognition of right of use assets	$	636,000			––
Initial recognition of lease liabilities	$	636,000			––

See accompanying notes to condensed consolidated financial statements 

7

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1-Business and Basis of Presentation

Business 

Asta Funding, Inc., a Delaware Corporation (the “Company,” “we” or “us”), together with its wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XXIII”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), EMIRIC, LLC (“EMIRIC”), Simia Capital, LLC (“Simia”), Sylvave, LLC (“Sylvave”) (formerly known as Pegasus Funding, LLC (“Pegasus”)), Arthur Funding LLC (“Arthur Funding”) (formerly known as Practical Funding, LLC (“Practical Funding”)), and other subsidiaries, which are not all wholly owned, is engaged in several business segments in the financial services industry including funding of personal injury claims, through the Company's wholly owned subsidiaries Sylvave, Simia and Arthur Funding, social security disability advocacy through the Company's wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables.

We operate principally in the United States in three reportable business segments: consumer receivables, social security disability advocacy and personal injury claims.

Consumer Receivables

This segment is engaged in the business of purchasing, managing for its own account and servicing distressed charged off receivables including consumer receivables. Recently, our effort has been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. We acquire these consumer receivables at substantial discounts to their face values, based on the characteristics of the underlying accounts of each portfolio. 

 Personal Injury Claims

This segment is comprised of purchased interests in personal injury claims from claimants who are a party to a personal injury claim. The Company advances to each claimant funds on a non-recourse basis at an agreed upon fee, in anticipation of a future settlement. The Company capitalizes employee compensation and benefits expenses as direct costs related to the origination of personal injury advances. Claims purchased consist of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Practical Funding on March 16, 2018 to continue in the personal injury claims funding business. On April 8, 2019, Practical Funding changed its name to Arthur Funding, LLC. Arthur Funding began funding advances on personal injury claims in May 2019 (see Note 5).

Simia commenced operations in January 2017, and conducts its business solely in the United States. Simia obtained its business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business was also obtained from its website and through attorneys. The personal injury claims segment includes the consolidated results of operations of Sylvave, Simia and Arthur Funding. Simia and Sylvave are not funding any new advances, but continue to collect on outstanding personal claim advances in the ordinary course.

Social Security Disability Advocacy 

This segment consists of advocacy groups representing individuals throughout the United States in their claims for social security disability and supplemental social security income benefits from the Social Security Administration and Department of Veterans Affairs. It relies upon Search Engine Optimization (“SEO”) to bring awareness to its intended market. 

8

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1-Business and Basis of Presentation (Continued)

Basis of Presentation 

The condensed consolidated balance sheet as of December 31, 2019, the condensed consolidated statements of operations for the three months ended December 31, 2019 and 2018, the condensed consolidated statements of comprehensive income (loss) for the three months ended December 31, 2019 and 2018, the condensed consolidated statements of stockholders’ equity as of and for the three months ended December 31, 2019, and the condensed consolidated statements of cash flows for the three months ended December 31, 2019 and 2018, are unaudited. The September 30, 2019 financial information included in this report was derived from our audited financial statements included in our Annual Report on Form 10 -K for the fiscal year ended September 30, 2019. In the opinion of management, all adjustments necessary to present fairly our financial position at December 31, 2019, the results of operations for the three months ended December 31, 2019 and 2018, the condensed consolidated statements of comprehensive income (loss) for the three months ended December 31, 2019 and 2018, the condensed consolidated statements of stockholders' equity for the three months ended December 31, 2019 and condensed consolidated statements of cash flows for the three months ended December 31, 2019 and 2018 have been made. The results of operations for the three months ended December 31, 2019 and 2018 are not necessarily indicative of the operating results for any other interim period or the full fiscal year. 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission and therefore do not include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019 filed with the Securities and Exchange Commission (the “2019 Form 10-K”).

The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and industry practices.

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

The condensed consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 Liquidity

 At December 31, 2019, the Company had $3.2 million in cash and cash equivalents, as well as $68.8 million in Level 1 securities within the fair value hierarchy that are classified as available for sale debt securities and investments in equity securities, on hand and no debt.  In addition, the Company had $90.2 million in stockholders' equity at December 31, 2019.

We believe that our available cash resources and expected cash inflows from operations will be sufficient to fund operations for at least the next twelve months.

Concentration of Credit Risk - Cash and Cash Equivalents

The Company considers all highly liquid investments with a maturity date of three months or less at the date of purchase to be cash equivalents.  

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company did not have cash balances with any domestic bank at December 31, 2019 that exceeded the balance insured by the FDIC limit. Two foreign banks with an aggregate $2.0 million balances are not FDIC insured. The Company does not believe it is exposed to any significant credit risk due to concentration of cash.

Investments in Equity Securities  

All equity investments in nonconsolidated entities are measured at fair value with changes recognized in earnings, except for those accounted for using the equity method of accounting. Changes in the fair value of equity securities are included in other income, net on the condensed consolidated statement of operations. 

9

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1-Business and Basis of Presentation (Continued)

Available-for-Sale Debt Securities  

Debt investments that the Company intends to hold for an indefinite period of time, but not necessarily to maturity, are classified as available-for-sale debt securities and are carried at fair value. Unrealized gains and losses on available-for-sale debt securities are determined using the specific-identification method. Unrealized gains/losses are recorded in other comprehensive income (loss).

Declines in the fair value of individual available-for-sale debt securities below their respective costs that are other than temporary will result in write-downs of the individual securities to their fair value. Factors affecting the determination of whether an other-than-temporary impairment has occurred include: a downgrading of the security by a rating agency, a significant deterioration in the financial condition of the issuer, or that management would not have the ability to hold a security for a period of time sufficient to allow for any anticipated recovery in fair value. 

Personal Injury Claim Advances and Impairments

The Company accounts for its investments in personal injury claims at an agreed upon fee, in anticipation of a future settlement. Purchased personal injury claim advances consists of the right to receive from a claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or reward with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse. When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon fee, and, if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.

Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collections of the fee income. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection of its initially funded cases as well as its fee income. 

Income Recognition - Consumer Receivables

The Company accounts for certain of its investments in consumer receivables using the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 310, Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method the Company concluded the cost recovery method is the appropriate accounting method under the circumstances.

Under the guidance of ASC 310, the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. At such time, all cash collections are recognized as revenue when received.

10

 ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1-Business and Basis of Presentation (Continued) 

Impairments - Consumer Receivables

The Company accounts for its impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC 310 is dependent on the Company having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event the Company cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected, ASC 310 permits the change to the cost recovery method. The Company will recognize income only after it has recovered its carrying value. 

If collection projections indicate the carrying value will not be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. The Company believes it has significant experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying customers. The Company invests in these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid so that it believes its estimated cash flow offers an adequate return on acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom the Company has limited experience, it has the added benefit of soliciting its third party collection agencies and attorneys for their input on liquidation rates and, at times, incorporates such input into the estimates it uses for its expected cash flows, and the Company’s ability to recover their cost basis. 

 Income Recognition - Social Security Disability Advocacy

In accordance with FASB ASC 606, Revenue from Contracts with Customers, the Company recognizes disability fee income for GAR Disability Advocates and Five Star when disability claimant’s cases close, when cash is received or when the Company receives a notice of award from the Social Security Administration (“SSA”) or the Department of Veterans Affairs that stipulates the amount of fee approved by the SSA to be paid to the Company. The Company establishes a reserve for the differentials in amounts awarded by the SSA compared to the actual amounts received by the Company. Fees paid to the Company are withheld by the SSA against the claimant's disability claim award, and are remitted directly to the Company from the SSA.

Commissions and fees  

Commissions and fees are the contractual commissions earned by third party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs and asset searches. The Company utilizes third party collection agencies and attorney networks.

Income taxes  

Deferred federal and state taxes arise from (i) recognition of finance income collected for tax purposes, but not yet recognized for financial reporting; (ii) provision for impairments/credit losses, all resulting in timing differences between financial accounting and tax reporting; (iii) amortization of intangibles resulting in timing differences between financial accounting and tax reporting; (iv) stock based compensation; and (v) partnership investments.

Fair Value Hierarchy 

FASB ASC 825, Financial Instruments, (“ASC 825”), requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

The Company records its available-for-sale debt securities and investments in equity securities at estimated fair value on a recurring basis. The accompanying condensed consolidated financial statements include estimated fair value information regarding its available-for-sale debt securities and investments in equity securities as of December 31, 2019, as required by FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement. 

11

 ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1-Business and Basis of Presentation (Continued)

Fair Value Hierarchy (continued)

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date.

Level 2 - Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are not active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 - Unobservable inputs that are supported by little or no market activity and significant to the fair value of the assets or liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use.

ASC 825 requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

Reclassification  

Certain prior period amounts in the accompanying condensed consolidated financial statements have been reclassified in connection with the immaterial error correction (included in Note 1 of our 2019 Form 10-K) to conform to the current year presentation.

Recent Accounting Pronouncements 

Adopted During the Three Months Ended December 31, 2019

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) which requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months. For a lease with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize a right-of-use asset and lease liability. Additionally, when measuring assets and liabilities arising from a lease, optional payments should be included only if the lessee is reasonably certain to exercise an option to extend the lease, exercise a purchase option or not exercise an option to terminate the lease. In January 2018, the FASB issued ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842 (“ASU 2018-01”). ASU 2018-01 was issued to address concerns about the cost and complexity of complying with the transition provisions of ASU 2016-02. Additionally, in July 2018, the FASB issued ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements, which provides an alternative transition method that permits an entity to use the effective date of ASU 2016-02 as the date of initial application through the recognition of a cumulative effect adjustment to the opening balance of retained earnings upon adoption. The standard became effective in for fiscal years beginning after December 15, 2018 and interim periods within those years, and early adoption is permitted (see Note 7 – Right of Use Assets). 

The Company adopted the lease accounting standard using the modified retrospective transition option on adoption on October 1, 2019, which had an immaterial impact to the Company’s condensed consolidated balance sheet. Upon adoption, the Company recorded additional lease liabilities of approximately $636,000 attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately $636,000. The Company used 3.5% as its incremental borrowing rate to calculate the net present value of its leases at October 1, 2019, based on the Company's estimated borrowing rate for a collateralized loan. The Company had no debt outstanding as of October 1, 2019.

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017, and requires certain disclosures about stranded tax effects. ASU 2018-02 was effective for the Company's fiscal year beginning October 1, 2019, with early adoption permitted, and were applied in the period of adoption in which the effect of the change in the U.S. federal corporate income tax rate in the Act was recognized. The adoption of this accounting update did not have a material impact on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For the Company, this update will be effective for interim periods and annual periods beginning after December 15, 2022. Upon adoption, the Company will accelerate the recording of its credit losses and is continuing to assess the impact on its consolidated financial statements. 

12

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1-Business and Basis of Presentation (Continued)

In January 2017, the FASB issued ASU 2017-04 Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step 2 from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after December 15, 2019, and interim periods within those fiscal years. The Company does not believe this update will have a material impact on its consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements. The ASU removes the requirement to disclose: the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. The ASU requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements. 

 In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning in fiscal 2022. The Company is evaluating the impact of the adoption of ASU 2019-12 on its financial statements, but does not expect such adoption to have a material impact.

Note 2-Investments in Debt and Equity Securities

Investments in Equity Securities  

Investments of equity securities at December 31, 2019 and September 30, 2019, consists of mutual funds valued at $8.2 million and $8.1 million, respectively.

Net gains and losses recognized on investments in equity securities for the three months ended December 31, 2019 and 2018 are as follows:

	Three Months Ended December 31, 2019		Three Months Ended December 31, 2018
Net gains and (losses) recognized during the period on equity securities	$	10,000	$	(29,000	)
Less: Net gains and (losses) recognized during the period on equity securities sold during the period		–		–
Unrealized gains and (losses) recognized during the reporting period on equity securities still held at the reporting date	$	10,000	$	(29,000	)

Available for Sale Debt Securities

Available for sale debt securities at December 31, 2019 and September 30, 2019, consist of the following:

13

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

December 31, 2019	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Available for sale debt securities	$	60,418,000	$	170,000	$	1,000	$	60,587,000

At December 31, 2018, the Company had $35.8 million in U.S. Treasury Bills, classified as available-for-sale debt securities on the Company's condensed consolidated balance sheet.  These U.S. Treasury bills had $135,000 (net of tax expense of $52,000) in unrealized gains that were recorded in other comprehensive income for the three months ended December 31, 2018.

September 30, 2019	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Available for sale debt securities	$	55,946,000	$	178,000	$	1,000	$	56,123,000

Note 2-Investments in Debt and Equity Securities (Continued)

Unrealized holding gains and losses on available for sale debt securities are included in other comprehensive income (loss) within stockholders’ equity. Realized gains (losses) on available for sale debt securities are included in other income (loss) and, when applicable, are reported as a reclassification adjustment in other comprehensive income (loss).  

Note 3-Consumer Receivables Acquired for Liquidation

Accounts acquired for liquidation are stated at cost and consist primarily of defaulted consumer loans of individuals throughout the United States and South America.

The following tables summarize the changes in the condensed consolidated balance sheet account of consumer receivables acquired for liquidation during the following periods:

	For the Three Months Ended December 31,
	2019			2018
Balance, beginning of period	$	1,668,000		$	3,749,000
Net cash collections		(3,375,000	)		(4,025,000	)
Impairment		(23,000	)		–
Effect of foreign currency translation		46,000			(147,000	)
Finance income recognized		3,132,000			3,494,000
Balance, end of period	$	1,448,000		$	3,071,000
Finance income as a percentage of collections		92.8	%		86.8	%

 During the three months ended December 31, 2019 and 2018 the Company did not purchase any new portfolios.

As of December 31, 2019, the Company held consumer receivables acquired for liquidation from Peru and Colombia of $0.9 million and $0.3 million, respectively. The total amount of foreign consumer receivables acquired for liquidation was $1.2 million, or 83.1% of the $1.4 million in total consumer receivables held at December 31, 2019. Of the total consumer receivables held domestically and internationally 4 individual portfolios comprise 25.2%, 16.9%, 14.5% and 10.0% of the overall asset balance at December 31, 2019.

As of September 30, 2019, the Company held consumer receivables acquired for liquidation from Peru and Colombia of $1.1 million and $0.3 million, respectively. The total amount of foreign consumer receivables acquired for liquidation was $1.4 million, or 83.8% of the total consumer receivables held of $1.7 million at September 30, 2019. Of the total consumer receivables held domestically and internationally 4 individual portfolios comprise 23.9%, 16.2%, 14.1% and 11.0% of the overall asset balance at September 30, 2019.

As of December 31, 2019, and September 30, 2019, 1.3% and 1.5% of the Company's total assets were related to its international operation, respectively. For the three months ended December 31, 2019 and 2018, 6.2% and 4.9% of the Company's total revenue related to its international operations, respectively.

At December 31, 2019, approximately 27% of the Company’s portfolio face value was serviced by five collection organizations.  At September 30, 2019, approximately 28% of the Company’s portfolio face value was serviced by five collection organizations. The Company has servicing agreements in place with these five collection organizations, as well as all of the Company’s other third-party collection agencies and attorneys that cover standard contingency fees and servicing of the accounts. While the 5 collection organizations represent only 27% and 28% as of December 31, 2019 and September 30, 2019, respectively, of the Company’s portfolio face value, it does represent approximately 86% and 86% of the Company’s portfolio face value at all third party collection agencies and attorneys as of December 31, 2019 and September 30, 2019, respectively.

14

 ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 3-Consumer Receivables Acquired for Liquidation (Continued)

The following table summarizes collections received by the Company’s third-party collection agencies and attorneys, less commissions and direct costs, for the three months ended December 31, 2019 and 2018, respectively. 

	For the Three Months Ended December 31,
	2019		2018
Gross collections (1)	$	6,549,000	$	8,220,000
Commissions and fees (2)		3,174,000		4,195,000
Net collections	$	3,375,000	$	4,025,000

(1)

Gross collections include collections from third party collection agencies and attorneys, collections from in-house efforts and collections represented by account sales.

(2)

Commissions are earned by third party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also received a 3% fee on gross collections received by the Company in connection with the related portfolio purchase.  The fee is charged for asset location and skip tracing in connection with this portfolio purchase.

 Note 4-Equity Method Investments

Serlefin Peru is a joint venture in which the Company has a 49% ownership interest. The other 51% is owned by three individuals who share common ownership with Serlefin BPO&O Serlefin S.A. (“Serlefin”). Each owner maintains voting rights equivalent to their share ownership, and the 51% shareholders collectively manage the operations of the business. Based on the Company's ownership and voting rights, the Company lacks requisite control of Serlefin Peru, and therefore accounts for its investment in Serlefin Peru under the equity method of accounting. 

Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of 80% and 20%, respectively. The purchased portfolios are transferred to an administrative and payment trust, where the Company and Serlefin are trustees. Serlefin provides collection services to the trust, and receives a performance fee determined by the parties for each loan portfolio acquired. Serlefin received approximately $0.3 million and $0.3 million in performance fees for the three months ended December 31, 2019 and 2018, respectively.

The carrying value of the investment in Serlefin Peru was $278,000 and $280,000 as of December 31, 2019 and September 30, 2019, respectively. The cumulative net loss from our investment in Serlefin Peru from the date of the initial investment through December 31, 2019 was approximately $256,000, and was not significant to the Company's condensed consolidated statement of operations.

Note 5-Personal Injury Claims Funding 

Simia and Sylvave

As of December 31, 2019, Simia had a personal injury claims portfolio of $1.1 million, and recognized revenue for the three months then ended of $16,000.   As of September 30, 2019, Simia had a personal injury claims portfolio of $1.3 million, and recognized revenue of $15,000 for the three months ended December 31, 2018.  

 As of December 31, 2019, Sylvave had a personal injury claims portfolio of $3.1 million, and recognized revenue for the three months then ended of $346,000.  As of September 30, 2019, Sylvave had a personal injury claims portfolio of $3.7 million, and recognized revenue of $699,000 for the three months ended December 31, 2018. 

Simia and Sylvave remain in operation to continue to collect on their outstanding personal injury claim portfolios, but will not be funding any new advances to claimants.

15

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) 

Note 5-Personal Injury Claims Funding (Continued)

Arthur Funding

Arthur Funding began funding advances on personal injury claims in May 2019. As of December 31, 2019, Arthur Funding had a personal injury claims portfolio of $0.3 million, and recognized revenue for the three months then ended of $14,000. As of September 30, 2019, Arthur Funding had a personal injury claims portfolio of $0.2 million, and no revenue was recognized for the three months ended December 31, 2018.  

The following tables summarize the changes in the balance sheet account of personal injury claim portfolios held by Simia, Sylvave and Arthur Funding, net of reserves, for the following periods: 

	December 31, 2019			December 31, 2018
Balance, beginning of period	$	5,190,000		$	10,745,000
Personal claim advances		49,000			–
(Write offs) recoveries		302,000			(203,000	)
Personal injury claims income		376,000			713,000
Personal injury claims receipts		(1,384,000	)		(2,442,000	)
Balance, end of period	$	4,533,000		$	8,813,000

 The Company recognized personal injury claims income of $0.4 million and $0.7 million for the three months ended December 31, 2019 and 2018, respectively. The Company has recorded a net reserve against its investment in personal injury claims of $1.1 million as of December 31, 2019 and $1.2 million as of September 30, 2019.

Note 6-Non-Recourse Debt

Non-Recourse Debt -Bank of Montreal (“BMO”)

In March 2007, Palisades XVI borrowed approximately $227 million under a Receivables Financing Agreement, as amended in July 2007, December 2007, May 2008, February 2009, October 2010 and August 2013 (the “RFA”) from BMO, in order to finance the Portfolio Purchase which had a purchase price of $300 million. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth and Fifth Amendments and the most recent agreement signed in August 2013. 

On August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement and Omnibus Amendment (the “BMO Settlement Agreement”) with BMO as an amendment to the RFA. In consideration for a $15 million prepayment funded by the Company, BMO agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO receives the next $15 million of collections from the Portfolio Purchase or from voluntary prepayments by the Company, less certain credits for payments made prior to the consummation of the BMO Settlement Agreement (the “Remaining Amount”), Palisades XVI and its affiliates would be automatically released from liability in connection with the RFA (subject to customary exceptions). A condition on the release was Palisades XVI’s agreement to grant BMO, as of the time of the payment of the Remaining Amount, the right to receive 30% of net collections from the Portfolio Purchase once Palisades XVI has received from future net collections, the sum of $15 million plus voluntary prepayments included in the payment of the Remaining Amount (the “Income Interest”). On June 3, 2014, Palisades XVI paid the Remaining Amount. The final principal payment of $2.9 million included a voluntary prepayment of $1.9 million provided from funds of the Company. Accordingly, Palisades XVI was entitled to receive $16.9 million of future collections from the Portfolio Purchase before BMO would be entitled to receive any payments with respect to its Income Interest.

During the month of June 2016, the Company received the balance of the $16.9 million and, as of December 31, 2019 and September 30, 2019, the Company recorded a liability to BMO of approximately $77,000 and $22,000, respectively, which has been recorded in accounts payable and accrued expenses on the Company’s consolidated balance sheet. The funds were subsequently remitted to BMO on January 10, 2020 and October 10, 2019, respectively. The liability to BMO is recorded when actual collections are received. 

16

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)  

Note 7 – Right of Use Assets and Liabilities

Effective October 1, 2019, the Company adopted ASU 2016-02, and all subsequent ASUs that modified Topic 842. For the Company, Topic 842 affected the accounting treatment for operating lease agreements in which the Company is the lessee by recognizing lease assets and liabilities on the balance sheet. The Company leases the premises for two New Jersey office facilities under operating lease agreements expiring in various years through 2023. The Company is responsible to pay all insurance, utilities, maintenance and repairs on the office spaces. All of the Company’s leases are classified as operating leases.

On October 1, 2019, the Company recorded additional lease liabilities of approximately $636,000 attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately $636,000. The Company used 3.5% as its incremental borrowing rate to calculate the net present value of its leases on October 1, 2019. As of December 31, 2019, the Company’s operating lease right-of-use assets and operating lease liabilities were approximately $545,000 and $540,000, respectively.

The Company leases office space in Englewood Cliffs, New Jersey and subleases office space in Fort Lee, New Jersey under agreements classified as operating leases.

The lease agreement in Englewood Cliffs, New Jersey expires on August 31, 2020 and does not include any renewal option. The lease agreement provides for an initial monthly base amount plus annual escalations through the term of the lease.

The sublease agreement in Fort Lee, New Jersey expires on March 31, 2023 and does not include any renewal option. The lease agreement provides for an initial monthly base amount plus certain additional amounts pursuant to the leasing arrangement between the landlord and sublessor.

In adopting the new accounting guidance, the Company used the following practical expedients for transitional relief as provided for in ASU 2018-01:

●An entity need not reassess whether any expired or existing contracts are or contain leases.

●An entity need not reassess the lease classification for any expired or existing leases.

●An entity need not reassess initial direct costs for any existing leases.

●An entity may elect to apply hindsight to leases that existed during the period from the beginning of the earliest period presented in the financial statements until the effective date.

The Company also elected not to include short-term leases (i.e., leases with initial terms of twelve months or less) or insignificant equipment leases on the condensed consolidated balance sheet as provided for in the accounting guidance.

The following provides additional information about the Company’s operating leases:

As of December 31, 2019:

Weighted average remaining lease term (in years)	2.40
Weighted average discount rate	3.5	%

As of December 31, 2019, the future minimum payments for the fiscal years are as follows:

2020	$	247,000
2021		122,000
2022		131,000
2023		65,000
Thereafter		–
Total lease payments		565,000
Less interest		(25,000	)
Operating lease liability	$	540,000

The Company leases its facilities in (i) Englewood Cliffs, New Jersey, and (ii) Fort Lee, New Jersey. Rent expense for the three months ended December 31, 2019 and 2018 was $0.1 million and $0.1 million, respectively.

17

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) 

Note 8 - Settlements

In August 2014, the Company filed a lawsuit in Delaware state court against a third-party servicer arising from the third-party servicer’s failure to pay the Company certain amounts that are due the Company under a servicing agreement. The third-party servicer filed a counterclaim in the Delaware action alleging that the Company owes certain amounts to the third-party servicer for court costs pursuant to an alleged arrangement between the companies. On or about July 12, 2018, the parties agreed to settle the action pursuant to a settlement agreement and release, which provides for, among other things, the payment by the third-party servicer of $4.4 million to the Company pursuant to an agreed upon schedule with a lump sum payment to be made at the third anniversary of the agreement.

These fee-based settlements are required to total $2.4 million and $4.4 million by the second and third anniversaries, respectively. To the extent that these fee-based settlement fees are less than these amounts, the servicer is required to make lump sum true-up payments.

The Company determined the fair value of this settlement using (i) historical collection history to estimate the fee based settlement fees that are expected to be received each month from the servicer; (ii) the contractual true-up dates, discussed above, in order to estimate the anticipated true-up payments that will be received from the servicer on the second and third anniversaries; and (iii) an imputed interest rate of 8.5%.

As of December 31, 2019, and September 30, 2019, the Company has a settlement receivable due from this third-party servicer of $1.1 million and $1.6 million, respectively. During the three months ended December 31, 2019, the Company received $0.5 million in payments from this third-party servicer. For the three months ended December 31, 2019 and 2018, the Company recorded $39,000 and $68,000 in interest income, which is included in other income on the Company's condensed consolidated statements of operations.

Note 9 – Interest, Dividend and Other Income

The following tables summarize interest, dividend and other income for the three months ended December 31, 2019 and 2018:

	December 31,
	2019		2018
Interest and dividend income	$	329,000	$	199,000
Realized gain		–		25,000
Unrealized gain (loss)		10,000		(29,000	)
Other		1,000		39,000
	$	340,000	$	234,000

Note 10 -Commitments and Contingencies

Legal Matters 

On November 7, 2019, a shareholder of the Company filed a verified shareholder derivative complaint in the Court of Chancery of the State of Delaware against certain current and former officers and directors of the Company, and named the Company as a nominal defendant, alleging that certain actions taken by management constituted a violation of fiduciary duty to the Company. The Company believes the lawsuit is without merit and intends to vigorously defend the matter. On or about January 8, 2020, a motion to dismiss the complaint was filed on behalf of all individual defendants and the Company as nominal defendant. 

In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using our network of third-party law firms, against consumers. Also, consumers occasionally initiate litigation against us, in which they allege that we have violated a federal or state law in the process of collecting their account. We do not believe that these ordinary course matters are material to our business and financial condition. The Company is not involved in any other material litigation in which we are a defendant. 

 Note 11 -Income Taxes  

 At the end of each interim reporting period, the Company estimates its effective income tax rate expected to be applicable for the full year. The estimate is used in providing for income taxes on a year-to-date basis and may change in subsequent interim periods. The Company’s effective tax rate from operations for the three months ended December 31, 2019 was 27.3%, compared to 27.9% in the same period of the prior year. The effective rate for fiscal 2020 and 2019 differed from the U.S. federal statutory rate of 21%, primarily due to state income taxes and other permanent differences. 

 The Company files income tax returns in the U.S federal jurisdiction, various state jurisdictions, and various foreign countries. The Company does not have any uncertain tax positions.

18

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 12 -Net Income per Share

Basic per share data is determined by dividing net income (loss) by the weighted average shares outstanding during the period. Diluted per share data is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. The assumed proceeds from the exercise of dilutive options are calculated using the treasury stock method based on the average market price for the period.  

The following table presents the computation of basic and diluted per share data for the three months ended December 31, 2019 and 2018:

	For the Three Months Ended December 31, 2019		For the Three Months Ended December 31, 2018
Net Income	$	1,045,000	$	1,275,000
Basic earnings per common share	$	0.16	$	0.19
Diluted earnings per common share	$	0.16	$	0.19
Weighted average number of common shares outstanding:
Basic		6,567,765		6,685,415
Dilutive effect of stock options		68,333		307
Diluted		6,636,098		6,685,722

At December 31, 2019 there were 85,000 stock options outstanding that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive.

Note 13-Stock Option Plans

2012 Stock Option and Performance Award Plan

On February 7, 2012, the Company adopted the 2012 Stock Option and Performance Award Plan (the “2012 Plan”), which was approved by the stockholders of the Company on March 21, 2012.

The 2012 Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights, in addition to the granting of stock options.

The Company authorized 2,000,000 shares of Common Stock for issuance under the 2012 Plan. Under the 2012 Plan, the Company has granted options to purchase an aggregate of 540,800 shares, awarded 245,625 shares of restricted stock, and has cancelled 115,268 options, leaving 1,328,843 shares available as of December 31, 2019. At December 31, 2019, 54 of the Company’s employees were able to participate in the 2012 Plan.

Equity Compensation Plan

On December 1, 2005, the Company adopted the Equity Compensation Plan (the “Equity Compensation Plan”), which was approved by the stockholders of the Company on March 1, 2006. The Equity Compensation Plan was adopted to supplement the Company’s 2002 Stock Option Plan (as defined below).

The Equity Compensation Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock options, stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights. 

The Company authorized 1,000,000 shares of Common Stock for issuance under the Equity Compensation Plan. As of March 21, 2012, no more awards could be issued under this plan.

19

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 13-Stock Option Plans (Continued)

2002 Stock Option Plan  

On March 5, 2002, the Company adopted the 2002 Stock Option Plan (the “2002 Plan”), which was approved by the stockholders of the Company on May 1, 2002. The 2002 Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company. 

The 2002 Plan authorized the granting of incentive stock options (as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) and non-qualified stock options to eligible employees of the Company, including officers and directors of the Company (whether or not employees) and consultants of the Company.  

The Company authorized 1,000,000 shares of Common Stock for issuance under the 2002 Plan. As of March 5, 2012, no more awards could be issued under this plan.

Summary of the Plans 

Compensation expense for stock options and restricted stock is recognized over the requisite vesting or service period. Compensation expense for restricted stock is based upon the market price of the shares underlying the awards on the grant date. 

The following table summarizes stock option transactions under the 2012 Plan, the Equity Compensation Plan and the 2002 Plan (collectively, the “Plans”):

	Three Months Ended December 31,
	2019					2018
	Number Of Shares			Weighted Average Exercise Price		Number of Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		722,567		$	8.18		728,867		$	8.17
Options forfeited/cancelled		(52,400	)		8.07		(334	)		7.93
Outstanding options at the end of period		670,167		$	8.19		728,533		$	8.17
Exercisable options at the end of period		670,167		$	8.19		728,533		$	8.17

The following table summarizes information about the Plans outstanding options as of December 31, 2019:

				Options Outstanding						Options Exercisable
Range of Exercise Price				Number of Shares Outstanding		Weighted Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number of Shares Exercisable		Weighted Average Exercise Price
	$5.7501	-	$8.6250		560,667		2.7		7.96		560,667		7.96
	$8.6251	-	$11.5000		109,500		3.1		9.37		109,500		9.37
					670,167		2.7	$	8.19		670,167	$	8.19

The Company recognized $0 and $7,000 of compensation expense related to the stock options vested during the three months ended December 31, 2019 and 2018, respectively. As of December 31, 2019, there was no unrecognized compensation cost related to stock option awards. 

The intrinsic value of the outstanding and exercisable options as of December 31, 2019 was approximately $1.4 million. The weighted average remaining contractual life of exercisable options is 2.7 years. There were no options exercised during the three months ended December 31, 2019 and 2018. The fair value of the stock options that vested during the three months ended December 31, 2019 and 2018 was approximately $0 and $76,000, respectively. There were no options granted during the three months ended December 31, 2019 and 2018. 

The Company did not grant any restricted stock awards during the three months ended December 31, 2019 and 2018. As of December 31, 2019, and September 30, 2019, there was no unrecognized compensation cost related to restricted stock awards. 

20

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 Note 14-Stockholders’ Equity 

 The Company has 5,000,000 authorized preferred shares with a par value of $0.01 per share. The Company’s board of directors (the “Board of Directors”) is authorized to divide the authorized shares of Preferred Stock into one or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes.

There were no shares of preferred stock issued and outstanding as of December 31, 2019 and 2018.

Dividends are declared at the discretion of the Board of Directors and depend upon the Company’s financial condition, operating results, capital requirements and other factors that the Board of Directors deems relevant. In addition, agreements with the Company’s lenders may, from time to time, restrict the ability to pay dividends. As of December 31, 2019, there were no such restrictions, as there were no lending agreements in place. No dividends were declared during fiscal year 2020.

Note 15-Fair Value of Financial Measurements and Disclosures  

Fair Value of Financial Instruments 

The estimated fair value of the Company’s financial instruments is summarized as follows:

	December 31, 2019				September 30, 2019
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Cash equivalents (Level 1)	$	66,000	$	66,000	$	64,000	$	64,000
Investments in equity securities (Level 1)		8,234,000		8,234,000		8,136,000		8,136,000
Available-for-sale debt securities (Level 2)		60,587,000		60,587,000		56,123,000		56,123,000
Consumer receivables acquired for liquidation (Level 3)		1,448,000		26,221,000		1,668,000		25,783,000

Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments:

Cash equivalents - The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value. 

Investments in equity securities - The investments in equity consist of mutual funds that are valued based on quoted prices in active markets. 

Available-for-sale debt securities - The available-for-sale debt securities consist of U.S. Treasury Bills that are valued based on quoted prices in active markets. The U.S. Treasury Bills have been classified as available for sale by the Company, as they are deemed to be short term investments, and can be liquidated as needed by the Company. 

The Company’s investments in equity securities and available-for-sale debt securities are classified as Level 1 and Level 2 financial instruments, respectively, based on the classifications described above. The Company did not have any transfers into (out of) Level 1 investments during the fiscal year ended September 30, 2018. The Company had no Level 3 available-for-sale investments during the three months ended December 31, 2019. 

Consumer receivables acquired for liquidation - The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of monthly collections for consumer receivables over the estimated collection period, which is currently January of 2020 through December of 2026. These cash flows are then fair valued using a discount rate of 20%. See Note 3 for the rollforward of Level 3 activity.

Note 16 – Related Party Transactions

The Company utilizes the services of a consultant in conjunction with its international operations. The consultant is the spouse of one of the owners of Serlefin Peru. For the three months ended December 31, 2019 and 2018, the Company paid this consultant $12,500 and $25,239, respectively. The Company does not have a formal agreement in place for these services, and the Company had no amounts due to this consultant as of December 31, 2019 and September 30, 2019.

On August 15, 2019, the Company and Lou Piccolo, a non-independent member of the Company’s Board of Directors, entered into a new one-year, $30,000 contract, pursuant to which Mr. Piccolo will provide consulting services. The compensation is to be paid quarterly. The Company recorded an expense of $7,500 for the three months ended December 31, 2019. There were no amounts due to Mr. Piccolo at December 31, 2019 and September 30, 2019.

21

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 17-Segment Reporting

The Company operates through strategic business units that are aggregated into three reportable segments: Consumer receivables, personal injury claims and social security disability advocacy. The three reportable segments consist of the following:

• Consumer Receivables - This segment is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including judgment receivables, charged off receivables and semi-performing receivables.  Judgment receivables are accounts where outside attorneys have secured judgments directly against the consumer. Primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of our distressed consumer receivables are MasterCard ®, Visa ® and other credit card accounts which were charged-off by the issuers or providers for non-payment. We acquire these and other consumer receivable portfolios at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. Recently, the Company's efforts have been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. The Company holds consumers receivable acquired for liquidation in both Colombia and Peru of approximately $1.2 million. The business conducts its activities primarily under the name Palisades Collection, LLC.

• Personal Injury Claims - This segment is comprised of purchased interests in personal injury claims from claimants who are a party in personal injury litigation or claims. The Company advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Arthur Funding, on March 16, 2018 to continue in the personal injury claims funding business. Arthur Funding began funding advances on personal injury claims in May 2019. Arthur Funding, Simia and Sylvave conduct its businesses solely in the United States and obtains business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business is also obtained from its website and through attorneys. Simia and Sylvave are not funding any new advances, but continue to collect on outstanding personal injury claim advances in the ordinary course.

• Social Security Benefit Advocacy - GAR Disability and Five Star are advocacy groups representing individuals throughout the United States in their claims for social security disability and supplemental security income benefits from the Social Security and Veterans Administration.

Certain non-allocated administrative costs, interest income and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, investments in equity securities and available-for-sale debt securities, a note receivable, property and equipment, goodwill, deferred taxes and other assets. 

22

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 17-Segment Reporting (Continued)

The following table shows results by reporting segment for the three months ended December 31, 2019 and 2018:

(Dollars in millions)	Consumer Receivables		Social Security Disability Advocacy		Personal Injury Claims		Corporate (2)			Total
Three Months Ended December 31,
2019:
Revenues	$	3.1	$	0.8	$	0.4	$	–		$	4.3
Other income		–		–		–		0.3			0.3
Segment profit (loss)		2.9		–		0.6		(2.1	)		1.4
Segment Assets (1)		7.2		1.0		4.8		79.5			92.5
2018:
Revenues	$	3.5	$	1.3	$	0.7	$	–		$	5.5
Other income		0.1		–		–		0.1			0.2
Segment profit (loss)		2.9		0.4		0.5		(2.1	)		1.7
Segment Assets (1)		12.0		1.4		10.1		62.6			86.1

The Company does not have any intersegment revenue transactions.

(1)	Includes other amounts in other line items on the condensed consolidated balance sheet.
(2)	Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.

23

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”)

Caution Regarding Forward Looking Statements

This Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included or incorporated by reference in this report, including without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs and plans and objective of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expects,” “intends,” “plans,” “projects,” “estimates,” “anticipates,” or “believes” or the negative thereof or any variation there on or similar terminology or expressions.

We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors which could materially affect our results and our future performance include, without limitation, the restatement of previously issued financial statements, the identified material weaknesses in our internal control over financial reporting and our ability to remediate those material weaknesses, our ability to purchase defaulted consumer receivables at appropriate prices, changes in government regulations that affect our ability to collect sufficient amounts on our defaulted consumer receivables, our ability to employ and retain qualified employees, changes in the credit or capital markets, changes in interest rates, deterioration in economic conditions, negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire, and statements of assumption underlying any of the foregoing, as well as other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019.

All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we assume no duty to update or revise any forward-looking statements.

Overview

Asta Funding, Inc., a Delaware Corporation (the “Company,” “we” or “us”), together with our wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XXIII”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), EMIRIC, LLC (“EMIRIC”), Simia Capital, LLC (“Simia”), Sylvave, LLC (“Sylvave”) (formerly known as Pegasus Funding, LLC (“Pegasus”)), Arthur Funding LLC (“Arthur Funding”) (formerly known as Practical Funding, LLC (“Practical Funding”)), and other subsidiaries, which are not all wholly owned, are engaged in several business segments in the financial services industry including funding of personal injury claims, through our wholly owned subsidiaries Sylvave, Simia and Arthur Funding, social security disability advocacy through our wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for our own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables.  

We operate principally in the United States in three reportable business segments: consumer receivables, social security disability advocacy and personal injury claims.  

For a detailed description of our segments, please read Note 17 - Segment Reporting, in our notes to condensed consolidated financial statements.

On October 30, 2019, Gary M. Stern, President and Chief Executive Officer, submitted a non-binding proposal (the “Proposal”) to the Board of Directors of the Company to acquire all of the outstanding shares of common stock, par value $0.01 per share (the “Shares”), of the Company at a cash purchase price of $10.75 per Share, representing a premium of approximately 60% over the closing price on October 29, 2019, and approximately 60% over the average closing price of the Company’s common stock for the 30 trading days preceding October 30, 2019. Mr. Stern plans only to acquire such Shares that are publicly held and the Proposal provides that he would do so through a merger of the Company with a newly formed acquisition vehicle that he would control.

The Company’s board of directors (the “Board of Directors”) has established a special committee of independent directors with its own independent advisors to review the Proposal.

24

 Financial Information About Operating Segments

The consumer receivables segment and the social security benefit advocacy segment each accounted for 10% or more of consolidated net revenue for the three months ended December 31, 2019 and 2018.  The Company accounted for its investment in Sylvave under the equity method of accounting through January 12, 2018, for subsequent periods we include the financial results of Sylvave in our consolidated statement of operations, while Simia and Arthur Funding are consolidated entities. The following table summarizes total revenues by percentage from our three lines of business for the three months ended December 31, 2019 and 2018:

	Three Months Ended December 31,
	2019			2018
Finance income (consumer receivables)		72.6	%		63.9	%
Personal injury claims income		8.7	%		13.0	%
Disability fee income		18.7	%		23.1	%
Total revenues		100.0	%		100.0	%

Information about the results of each of our reportable segments for the three-month periods ended December 31, 2019 and 2018, reconciled to the consolidated results, are set forth below. Separate segment MD&A is not provided, as segment revenue corresponds to the revenue presented in our condensed consolidated statement of operations, and material expense items are not allocable to any specific segment.

(Dollars in millions)	Consumer Receivables		Social Security Disability Advocacy		Personal Injury Claims		Corporate (2)			Total
Three Months Ended December 31,
2019:
Revenues	$	3.1	$	0.8	$	0.4	$	–		$	4.3
Other income		–		–		–		0.3			0.3
Segment profit (loss)		2.9		0.0		0.6		(2.1	)		1.4
Segment Assets (1)		7.2		1.0		4.8		79.5			92.5
2018:
Revenues	$	3.5	$	1.3	$	0.7	$	–		$	5.5
Other income		0.1		–		–		0.1			0.2
Segment profit (loss)		2.9		0.4		0.5		(2.1	)		1.7
Segment Assets (1)		12.0		1.4		10.1		62.6			86.1

We do not have any intersegment revenue transactions.

(1)	Includes other amounts in other line items on the condensed consolidated balance sheet.
(2)	Corporate is not part of our three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment

Consumer Receivables  

The consumer receivable portfolios generally consist of one or more of the following types of consumer receivables: 

• charged-off receivables - accounts that have been written-off by the originators and may have been previously serviced by collection agencies; and

• semi-performing receivables - accounts where the debtor is making partial or irregular monthly payments, but the accounts may have been written-off by the originators.

 We acquire these consumer receivable portfolios at a significant discount to the amount actually owed by the borrowers. We acquire these portfolios after a qualitative and quantitative analysis of the underlying receivables and calculate the purchase price so that our estimated cash flow offers us an adequate return on our investment after servicing expenses. After purchasing a portfolio, we actively monitor its performance and review and adjust our collection and servicing strategies accordingly.  

25

We purchase receivables from credit grantors and others through privately negotiated direct sales, brokered transactions and auctions in which sellers of receivables seek bids from several pre-qualified debt purchasers. We pursue new acquisitions of consumer receivable portfolios on an ongoing basis through:

• our relationships with industry participants, financial institutions, collection agencies, investors and our financing sources;

• brokers who specialize in the sale of consumer receivable portfolios; and

• other sources.

Personal Injury Claims

This Company’s personal injury claims business segment is comprised of purchased interests in personal injury claims from claimants who are a party in personal injury litigation or claims. The Company advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Arthur Funding, on March 16, 2018 to continue in the personal injury claims funding business. Arthur Funding began funding advances on personal injury claims in May 2019. Arthur Funding, Simia and Sylvave conduct its businesses solely in the United States and obtains business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business is also obtained from its website and through attorneys. Simia and Sylvave are not funding any new advances, but continue to collect on outstanding personal injury claim advances in the ordinary course.

Social Security Disability Advocacy Business

GAR Disability Advocates and Five Star are disability advocacy groups, which for a fee obtain and represent individuals throughout the United States in their claims for social security disability, supplemental security income benefits from the Social Security Administration and veterans benefits with the Veteran's Administration.

Critical Accounting Policies

Income Recognition - Consumer Receivables   

We account for certain of our investments in consumer receivables using the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 310, Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method, we concluded the cost recovery method is the appropriate accounting method under the circumstances. 

Under the guidance of ASC 310, we must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).  

We use the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received. 

Impairments - Consumer Receivables

We account for our impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC 310 is dependent on us having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event we cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected. ASC 310 permits the change to the cost recovery method. We will recognize income only after we have recovered our carrying value.

26

If collection projections indicate the carrying value will not be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. We believe we have significant experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying customers. We invest in these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid so that it believes its estimated cash flow offers an adequate return on acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom we have limited experience, it has the added benefit of soliciting its third party collection agencies and attorneys for their input on liquidation rates and, at times, incorporates such input into the estimates it uses for its expected cash flows, and our ability to recover our cost basis. For the three months ended December 31, 2019, we recorded impairment of our international portfolios by $23,000. For the three months ended December 31, 2018, we did not record any impairments on our domestic or international portfolios.

Personal Injury Claim Advances and Impairments

We account for our investments in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. Our interest purchased in personal injury claim advances consists of the right to receive from a claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or reward with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued at a rate based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse. When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon interest rate, and, if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant. 

We assess the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. We specifically reserve for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, we establish reserves based on the historical collection rates of our fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, we also monitor our historical collection rates on fee income and establish reserves on fee income consistent with the historically experienced collection rates. We regularly analyze and update the historical collection rates of our initially funded cases as well as our fee income.

Income Recognition - Social Security Disability Advocacy

In accordance with FASB ASC 606, Revenue from Contracts with Customers, we recognize disability fee income for GAR Disability Advocates and Five Star when disability claimant’s cases close, when cash is received, or when we receive a notice of award from the Social Security Administration (“SSA”) that stipulates the amount of fee approved by the SSA to be paid to us. We establish a reserve for the differentials in amounts awarded by the SSA and Veterans Administration compared to the actual amounts received by us. Fees paid to us are withheld by the SSA and Veterans Administration against the claimant's disability claim award, and are remitted directly to us from the SSA and Veterans Administration.

In the following discussions, most percentages and dollar amounts have been rounded to aid in the presentation. As a result, all figures are approximations.   

27

Results of Operations    

Three Months Ended December 31, 2019, Compared to the Three Months Ended December 31, 2018  

Finance income. For the three months ended December 31, 2019, finance income decreased $0.4 million, or 10.4%, to $3.1 million from $3.5 million for the three months ended December 31, 2018. The decrease in finance income was due to reduction in the collections on portfolios during the three months ended December 31, 2019 compared to the three months ended December 31, 2018 and the overall age of the portfolios. During the three months ended December 31, 2019 and 2018, the Company did not purchase any consumer portfolios. Net collections for the three months ended December 31, 2019 decreased 16.1% to $3.4 million from $4.0 million for the three months ended December 31, 2018.  For the three months ended December 31, 2019 gross collections decreased 20.3%, or $1.7 million, to $6.5 million from $8.2 million for the three months ended December 31, 2018. For the three months ended December 31, 2019 commissions and fees associated with gross collections from our third-party collection agencies and attorneys decreased 24.3% or $1.0 million to $3.2 million from $4.2 million for the three months ended December 31, 2018. Commissions and fees amounted to 48.5% of gross collections for the three months ended December 31, 2019, compared to 51.0% for the three months ended December 31, 2018 resulting from lower percentage of commissionable collections in the current year period.

Management’s outlook for our Consumer Receivables business segment is that we expect that Finance income may continue to decline due to the continued aging of our existing credit card portfolios.  Although we may purchase new portfolios in future periods, we may not be able to purchase consumer receivable portfolios domestically at favorable prices or on sufficient terms. The expected decline in our future Finance income may have a negative impact on our Consumer Receivables business segment and our consolidated pre-tax profits in fiscal 2020 and future periods.

Personal Injury Claims income. Personal injury claims income decreased 47.3% or $0.3 million to $0.4 million for the three months ended December 31, 2019 from $0.7 million for the three months ended December 31, 2018 as a result of lower new advances in Arthur Funding and continued collections on historical personal injury claims.

Social security benefit advocacy fee income. Disability fee income decreased $0.5 million, or 35.9%, to $0.8 million for the three months ended December 31, 2019 from $1.3 million for the three months ended December 31, 2018, due to decrease in average fees per case earned for the disability claimants’ cases closed with the Social Security and Veterans Administration during the current quarter.

Management’s outlook for our Social Security Disability Advocacy business segment is that revenue and segment profitability may be lower for the full year of fiscal 2020 as compared with the full year of fiscal 2019.  This full year outlook for fiscal 2020 is attributable to the decline in our first quarter revenue and segment profit in the first quarter of fiscal 2020 as compared with the first quarter of fiscal 2019 and the fourth quarter of fiscal 2019.

Earnings (loss) from equity method investee. Earnings from equity method investment increased by $26,000 to a loss of $4,000 for the three months ended December 31, 2019 from a loss of $30,000 during the three months ended December 31, 2018.

Interest and dividend income. Interest and dividend income increased $0.1 million, or 65% to $0.3 million for the three months ended December 31, 2019 from $0.2 million for the three months ended December 31, 2018, due to higher balances in U.S. Treasury securities.

Other income, net. The following table summarizes other income for the three months ended December 31, 2019 and 2018:

	December 31,
	2019		2018
Realized gain	$	–	$	25,000
Unrealized gain (loss)		10,000		(29,000	)
Other		1,000		39,000
	$	11,000	$	35,000

General and administrative expenses.  For the three months ended December 31, 2019, general and administrative expense decreased $0.7 million, or 18.7%, to $3.2 million from $3.9 million for the three months ended December 31, 2018, primarily due to a decrease in bad debt expense of $0.5 million and a favorable foreign exchange variance of $0.5 million offset by increase in outside services of $0.3 million.

Segment profit - Consumer Receivables. Segment profit remained flat at $2.9 million for the three months ended December 31, 2019 and 2018. The revenue decreased by $0.4 million for the three months ended December 31, 2019 to $3.1 million from $3.5 million for the three months ended December 31, 2018 but offset by favorable foreign exchange variance of $0.5 million and an increase in collection expenses of $0.1 million.

Segment profit - Personal Injury Claims. Segment profit increased $0.1 million to $0.6 million for the three months ended December 31, 2019, from $0.5 million for the three months ended December 31, 2018. This increase in profitability is a result of decreased revenue of $0.3 million and increase in various operating expenses of $0.1 million offset by a decrease in bad debt expense of $0.5 million.

Segment loss – Social Security Disability Advocates. The Segment profit was $36,000 for the three months ended December 31, 2019 as compared to segment profit of $0.4 million for the three months ended December 31, 2018. The decrease in profitability of $0.4 million in the current fiscal year is primarily the result of decreased revenue of $0.5 million in the current year. 

Income tax expense. Income tax expense, consisting of federal and state components, for three months ended December 31, 2019, was $0.4 million, a decrease of $0.1 million as compared to the three months ended December 31, 2018. The decrease in income tax expense was primarily related to a larger percentage of pre-tax income being generated by our foreign operations.

28

Net income. As a result of the above, we generated net income for the three months ended December 31, 2019 of $1.0 million, compared to $1.3 million for the three months ended December 31, 2018.

Liquidity and Capital Resources

Our primary source of cash from operations is collections on the receivable portfolios we have acquired and the funds generated from the liquidation of our personal injury claim portfolios. Our primary uses of cash include costs involved in the collection of consumer receivables, the liquidation of our personal injury portfolio, and the costs to run our disability advocacy business.

Receivables Financing Agreement

 In March 2007, Palisades XVI borrowed approximately $227 million under the Receivables Financing Agreement, as amended in July 2007, December 2007, May 2008, February 2009, October 2010 and August 2013 (the “RFA”) from BMO, in order to finance the Portfolio Purchase which had a purchase price of $300 million. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth, Fifth Amendments and the most recent agreement signed in August 2013.

Financing Agreement. August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement (the “BMO Settlement Agreement”) with BMO as an amendment to the RFA. In consideration for a $15 million prepayment funded by the Company, BMO has agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO were to receive the next $15 million of collections from the Portfolio Purchase, (the “Remaining Amount”) less certain credits for payments made prior to the consummation of the BMO Settlement Agreement, Palisades XVI would be entitled to recover from future net collections the $15 million prepayment that it funded. Thereafter, BMO would have the right to receive 30% of future net collections. Upon repayment of the Remaining Amount to BMO, Palisades XVI would be released from the remaining contractual obligation of the RFA. 

On June 3, 2014, Palisades XVI finished paying the Remaining Amount. The final principal payment of $2.9 million included a voluntary prepayment of $1.9 million provided from funds of the Company. Accordingly, Palisades XVI was entitled to receive $16.9 million of future collections from the Portfolio Purchase before BMO is entitled to receive any payments with respect to its Income Interest. During the month of June 2016, we received the balance of the $16.9 million, and, as of December 31, 2019, we recorded a liability to BMO of approximately $0.1 million. The funds were subsequently remitted to BMO on January 10, 2020. The liability to BMO is recorded when actual collections are received. 

Cash Flow  

At December 31, 2019, our cash decreased $1.1 million to $3.2 million from $4.3 million at September 30, 2019. Our cash balance remained consistent, due to the fact we invested all excess cash in US Treasury bills, which are accounted for as available for sale debt securities on our condensed consolidated balance sheet.

Net cash provided by operating activities was $1.8 million during the three months ended December 31, 2019, as compared to $1.9 million for the three months ended December 31, 2018, primarily resulting from the decrease in net income of $0.3 million in the current period compared to $1.3 million in the prior year period, decrease in provision for bad debts for personal injury claims of $0.5 million offset by increase in other assets and liabilities of $0.6 million. Net cash used in investing activities was $2.9 million during the three month period ended December 31, 2019, as compared to $2.2 million during the three month period ended December 31, 2018. The change in cash used in investing activities is primarily due to the decrease in the personal injury claims receipts of $0.7 million and lower principal collected on receivables acquired for liquidation of $0.3 million in the current period compared to the prior period, proceeds from notes receivable of $0.5 million in the prior year period offset by lower net investment in available for sale securities of $0.8 million in the current year compared to the prior year period. There was no cash provided by financing activities during the three months ended December 31, 2019 and in the same prior year period.

Our cash requirements have been and will continue to be significant to operate our various lines of business. Significant requirements include costs involved in the collections of consumer receivables, investment in consumer receivable portfolios and investment in personal injury claims. In addition, dividends could be declared and paid if and when approved by the Board of Directors. Acquisitions recently have been financed through cash flows from operating activities. We believe we will not be dependent on a credit facility in the short-term, as our cash balances will be sufficient to invest in personal injury claims, purchase portfolios and finance the disability advocacy business.

We believe our available cash resources and expected cash flows from operations will be sufficient to fund operations for at least the next twelve months. We do not expect to incur any material capital expenditures during the next twelve months. 

29

We are cognizant of the current market fundamentals in the debt purchase and company acquisition markets which, because of significant supply and tight capital availability, could result in increased buying opportunities. The outcome of any future transaction(s) is subject to market conditions. In addition, due to these opportunities, we may seek opportunities with banking organizations and others on a possible financing loan facility.

Off Balance Sheet Arrangements  

We do not have any off-balance sheet arrangements.

Additional Supplementary Information:

We do not anticipate collecting the majority of the purchased principal amounts of our various portfolios. Accordingly, the difference between the carrying value of the portfolios and the gross receivables is not indicative of future revenues from these accounts acquired for liquidation. Since we purchased these accounts at significant discounts, we anticipate collecting only a portion of the face amounts. 

For additional information regarding our methods of accounting for our investment in finance receivables, the qualitative and quantitative factors we use to determine estimated cash flows, and our performance expectations of our portfolios, see “ Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies ” above.

Recent Accounting Pronouncements

Adopted During The Three Months Ended December 31, 2019   

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) which requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months. For a lease with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize a right-of-use asset and lease liability. Additionally, when measuring assets and liabilities arising from a lease, optional payments should be included only if the lessee is reasonably certain to exercise an option to extend the lease, exercise a purchase option or not exercise an option to terminate the lease. In January 2018, the FASB issued ASU 2018-01, “Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842 (“ASU 2018-01”). ASU 2018-01 was issued to address concerns about the cost and complexity of complying with the transition provisions of ASU 2016- 02. Additionally, in July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements, which provides an alternative transition method that permits an entity to use the effective date of ASU 2016-02 as the date of initial application through the recognition of a cumulative effect adjustment to the opening balance of retained earnings upon adoption. The standard became effective in for fiscal years beginning after December 15, 2018 and interim periods within those years, and early adoption is permitted (see Note 7 – Right of Use Assets and Liabilities). 

The Company adopted the lease accounting standard using the modified retrospective transition option on adoption on October 1, 2019, which had an immaterial impact to the Company’s condensed consolidated balance sheet. Upon adoption, the Company recorded additional lease liabilities of approximately $636,000 attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately $636,000. The Company used 3.5% as its incremental borrowing rate to calculate the net present value of its leases at October 1, 2019, based on the Company's estimated borrowing rate for a collateralized loan. The Company had no debt outstanding as of October 1, 2019.

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017, and requires certain disclosures about stranded tax effects. ASU 2018-02 was effective for the Company's fiscal year beginning October 1, 2019, with early adoption permitted, and were applied in the period of adoption in which the effect of the change in the U.S. federal corporate income tax rate in the Act was recognized. The adoption of this accounting update did not have a material impact on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). The ASU 2016-13 requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For the Company, this update will be effective for interim periods and annual periods beginning after December 15, 2022. Upon adoption, the Company will accelerate the recording of its credit losses and is continuing to assess the impact on its consolidated financial statements.

30

In January 2017, the FASB issued ASU 2017-04 Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). The objective of ASU 2017-04 is to simplify the subsequent measurement of goodwill, by eliminating step 2 from the goodwill impairment test. The amendments in ASU 2017-04 are effective for annual periods beginning after December 15, 2019, and interim periods within those fiscal years. We do not believe ASU 2017-04 will have a material impact on its consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). ASU 2018-13 modifies the disclosure requirements on fair value measurements. The ASU removes the requirement to disclose: the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2018-13 requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact ASU 2018-13 will have on our consolidated financial statements. 

 In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning in fiscal 2022. The Company is evaluating the impact of the adoption of ASU 2019-12 on its financial statements, but does not expect such adoption to have a material impact.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2019. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of December 31, 2019 due to the existence of the material weaknesses in internal control over financial reporting described below (which we view as an integral part of our disclosure controls and procedures).

We did not design and implement effective control over our control environment, risk assessment, control activities and monitoring activities with regard to our processes and procedures commensurate with our financial reporting requirements which we determined to be material weaknesses. Specifically, our control deficiencies are in the following areas:

Control Environment and Risk Assessment:

● The Company did not design and implement a sufficient level of formal financial reporting and operating policies and procedures that define how transactions are initiated, processed, approved, recorded and appropriately reported and disclosed within the annual and interim consolidated financial statements.

● The Company did not maintain sufficient policies and procedures to ensure that financial statement disclosures are complete, accurate and comply with professional standards.

● The Company did not maintain a sufficient number of personnel with the necessary level of accounting knowledge, experience, and training in the application of U.S. GAAP commensurate with its financial reporting requirements and the complexity of the Company’s operations and transactions.

Control Activities:

● The Company did not maintain and document control activities designed and implemented to identify, review and report, on a timely basis, related party transactions, and account for unusual, non-recurring complex transactions and income taxes.

● The Company did not maintain and document internal controls with sufficient precision designed to provide reasonable assurance related to third party service providers and third-party advocates providing cash collection and advocacy services including the completeness and accuracy of related information.

Monitoring Activities:

The Company did not maintain effective monitoring and review activities including communicating deficiencies in a timely manner to those parties responsible for taking corrective action.

Management’s Remediation Plan

Management has initiated a remediation plan to address the control deficiencies that led to the material weaknesses. The remediation plan includes, but is not limited to:

31

● The Company established a Disclosure Committee, which now meets on a quarterly basis, and to meet more frequently throughout the year to assure that our public disclosures are complete, accurate, and otherwise comply with applicable accounting principles and regulations. The Company’s Disclosure Committee reports to our Chief Executive Officer with oversight provided by our Audit Committee, and includes individuals knowledgeable about, among other things, SEC rules and regulations, financial reporting, and internal control matters.

● The Company has installed contract management software to manage all of its contracts and associated obligations under those contracts. Management from each department has been trained on the software, and all contracts now require approvals of designated managers and the accounting department prior to execution.

● The Company has increased the frequency of onsite inspections of third-party servicers during 2019, utilizing existing accounting/finance personnel familiar with the specific accounting processes involved at each location. The Company has provided training to accounting personnel at subsidiary locations, and developed detailed checklist and processes that were used and reviewed by management during period ends.

● The Company began developing policies, procedures, and controls to ensure the proper accounting for complex technical issues are identified, researched and brought to management's attention. The Company trained the appropriate personnel on new and existing accounting pronouncements, Company policies, procedures, and controls.

● The Company implemented changes to the software that manages the social security disability business, to reconcile the amounts received in cash from the Social Security Administration ("SSA") to SSA's notice of award. Additionally, applicable personnel were trained on the new software modifications to ensure compliance in the input and maintenance of claimant's files.

We continue to make progress on our remediation plan and our goal is to formally document and test the operating effectiveness of our newly implemented or modified internal controls in 2020. Until the controls are remediated, we will continue to perform additional account analysis, substantive testing and other post-closing procedures to ensure that our consolidated financial statements and prepared in accordance with U.S. GAAP.

Changes in Internal Controls over Financial Reporting.

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated our internal control over financial reporting to determine whether any changes occurring during the first quarter of fiscal year 2020 that have materially affected, or are reasonably likely to affect, our internal control over financial reporting. Management has concluded that there have been no changes that occurred during such quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.   Legal Proceedings

In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using third party law firms, against consumers. Also, consumers occasionally initiate litigation against us, in which they allege that we have violated a federal or state law in the process of collecting on their account. We do not believe that these ordinary course matters are material to our business and financial condition. As of the date of this report, we were not involved in any material litigation in which we were a defendant.

Originators, debt purchasers and third-party collection agencies and attorneys in the consumer credit industry are frequently subject to putative class action lawsuits and other litigation. Claims include failure to comply with applicable laws and regulations and improper or deceptive origination and servicing practices. Being a defendant in such class action lawsuits or other litigation could materially adversely affect our results of operations and financial condition.

Legal proceedings are subject to substantial uncertainties concerning the outcome of material factual and legal issues relating to the litigation. Accordingly, we cannot currently predict the manner and timing of the resolution of some of these matters and may be unable to estimate a range of possible losses or any minimum loss from such matters.

On November 7, 2019, a shareholder of the Company filed a verified shareholder derivative complaint in the Court of Chancery of the State of Delaware against certain current and former officers and directors of the Company, and named the Company as a nominal defendant, alleging that certain actions taken by management constituted a violation of fiduciary duty to the Company. The Company believes the lawsuit is without merit and intends to vigorously defend the matter. On or about January 8, 2020, a motion to dismiss the complaint was filed on behalf of all individual defendants and the Company as nominal defendant.

32

Item 1A.  Risk factors

For a discussion of our potential risks and uncertainties, see the information previously disclosed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K, for the year ended September 30, 2019 filed with the SEC on December 20, 2019. There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K. 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3. Default Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None 

Item 6. Exhibits

(a) Exhibits.

31.1*	Certification of Gary Stern, Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of  Steven Leidenfrost, Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Gary Stern, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*	Certification of  Steven Leidenfrost, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance.
101.SCH	XBRL Taxonomy Extension Schema.
101.CAL	XBRL Taxonomy Extension Calculation.
101.DEF	XBRL Taxonomy Extension Definition.
101.LAB	XBRL Taxonomy Extension Labels.
101.PRE	XBRL Taxonomy Extension Presentation.

* Filed herewith.

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ASTA FUNDING, INC. (Registrant)
Date: February 21, 2020	By:	/s/ Gary Stern
		Gary Stern, President, Chief Executive Officer
		(Principal Executive Officer)
Date: February 21, 2020	By:	/s/ Steven Leidenfrost
		Steven Leidenfrost, Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

34

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Gary Stern, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Asta Funding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 21, 2020

/s/ Gary Stern

Gary Stern

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Steven Leidenfrost, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Asta Funding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 21, 2020

/s/ Steven Leidenfrost

Steven Leidenfrost

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Asta Funding, Inc. (the “Company”) for the quarter ended December 31, 2019, filed with the Securities and Exchange Commission (the “Report”), I, Gary Stern, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

Date: February 21, 2020

/s/ Gary Stern

Gary Stern

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Asta Funding, Inc. (the “Company”) for the quarter ended December 31, 2019, filed with the Securities and Exchange Commission (the “Report”), I, Steven Leidenfrost, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

Dated: February 21, 2020 

/s/ Steven Leidenfrost

Steven Leidenfrost

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

XML

Note 12 - Net Income Per Share - Computation of Basic and Diluted Per Share Data (Details) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Net Income	$ 1,045,000	$ 1,275,000
Basic earnings per common share (in dollars per share)	$ 0.16	$ 0.19
Diluted earnings per common share (in dollars per share)	$ 0.16	$ 0.19
Basic (in shares)	6,567,765	6,685,415
Incremental Common Shares Attributable to Share-based Payment Arrangements, Total	68,333	307
Diluted (in shares)	6,636,098	6,685,722

XML

Note 8 - Settlements (Details Textual) - USD ($)				3 Months Ended
	Jul. 12, 2020	Jul. 12, 2019	Jul. 12, 2018	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019
Receivable, Settlement				$ 1,095,000		$ 1,558,000
Lawsuit in Delaware State Court [Member]
Loss Contingency, Damages Awarded, Value			$ 4,400,000
Litigation Settlement, Amount Awarded from Other Party	$ 4,400,000	$ 2,400,000
Litigation Settlement, Imputed Interest Rate			8.50%
Receivable, Settlement				1,100,000		$ 1,600,000
Gain (Loss) Related to Litigation Settlement, Total				500,000
Litigation Settlement Interest				$ 39,000	$ 68,000

XML

Note 14 - Stockholders' Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Issued, Total	0	0	0
Dividends, Total	$ 0
Preferred Stock, Shares Outstanding, Ending Balance	0	0	0

XML

Note 8 - Settlements

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Legal Matters and Contingencies [Text Block]

Note

8

- Settlements

In

August 2014,

the Company filed a lawsuit in Delaware state court against a

third

-party servicer arising from the

third

-party servicer’s failure to pay the Company certain amounts that are due the Company under a servicing agreement. The

third

-party servicer filed a counterclaim in the Delaware action alleging that the Company owes certain amounts to the

third

-party servicer for court costs pursuant to an alleged arrangement between the companies. On or about

July 12, 2018,

the parties agreed to settle the action pursuant to a settlement agreement and release, which provides for, among other things, the payment by the

third

-party servicer of

$4.4

million to the Company pursuant to an agreed upon schedule with a lump sum payment to be made at the

third

anniversary of the agreement.

These fee-based settlements are required to total

$2.4

million and

$4.4

million by the

second

and

third

anniversaries, respectively. To the extent that these fee-based settlement fees are less than these amounts, the servicer is required to make lump sum true-up payments.

The Company determined the fair value of this settlement using (i) historical collection history to estimate the fee based settlement fees that are expected to be received each month from the servicer; (ii) the contractual true-up dates, discussed above, in order to estimate the anticipated true-up payments that will be received from the servicer on the

second

and

third

anniversaries; and (iii) an imputed interest rate of

8.5%.

As of

December 31, 2019,

and

September 30, 2019,

the Company has a settlement receivable due from this

third

-party servicer of

$1.1

million and

$1.6

million, respectively. During the

three

months ended

December 31, 2019,

the Company received

$0.5

million in payments from this

third

-party servicer. For the

three

months ended

December 31, 2019

and

2018,

the Company recorded

$39,000

and

$68,000

in interest income, which is included in other income on the Company's condensed consolidated statements of operations.

XML

Note 4 - Equity Method Investments

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Equity Method Investments and Joint Ventures Disclosure [Text Block]

 

Note

4

-Equity Method Investments

Serlefin Peru is a joint venture in which the Company has a

49%

ownership interest. The other

51%

is owned by

three

individuals who share common ownership with Serlefin BPO&O Serlefin S.A. (“Serlefin”). Each owner maintains voting rights equivalent to their share ownership, and the

51%

shareholders collectively manage the operations of the business. Based on the Company's ownership and voting rights, the Company lacks requisite control of Serlefin Peru, and therefore accounts for its investment in Serlefin Peru under the equity method of accounting. 

Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of

80%

and

20%,

respectively. The purchased portfolios are transferred to an administrative and payment trust, where the Company and Serlefin are trustees. Serlefin provides collection services to the trust, and receives a performance fee determined by the parties for each loan portfolio acquired. Serlefin received approximately

$0.3

million and

$0.3

million in performance fees for the

three

months ended

December 31, 2019

and

2018,

respectively.

The carrying value of the investment in Serlefin Peru was

$278,000

and

$280,000

as of

December 31, 2019

and

September 30, 2019,

respectively. The cumulative net loss from our investment in Serlefin Peru from the date of the initial investment through

December 31, 2019

was approximately

$256,000,

and was

not

significant to the Company's condensed consolidated statement of operations.

XML

Note 2 - Investments in Debt and Equity Securities (Details Textual) - USD ($)	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2019	Sep. 30, 2019
Equity Securities, FV-NI		$ 8,234,000	$ 8,136,000
Debt Securities, Available-for-sale, Total		$ 60,587,000	$ 56,123,000	[1]
US Treasury Securities [Member]
Debt Securities, Available-for-sale, Total	$ 35,800,000
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax, Total	135,000
Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax, Total	$ 52,000

[1] At September 30, 2018, the Company reported investments in equity securities and available for sale debt securities as a single line item on the Company's condensed consolidated balance sheet. With the Company's adoption of ASU No. 2016-01 on October 1, 2018, the Company has included the current breakout above for comparability purposes only.

XML

Note 5 - Personal Injury Claims Funding (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Personal Claims Funding [Table Text Block]

	December 31, 2019			December 31, 2018
Balance, beginning of period	$	5,190,000		$	10,745,000
Personal claim advances		49,000			–
(Write offs) recoveries		302,000			(203,000	)
Personal injury claims income		376,000			713,000
Personal injury claims receipts		(1,384,000	)		(2,442,000	)
Balance, end of period	$	4,533,000		$	8,813,000

XML

Note 13 - Stock Option Plans (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Share-based Payment Arrangement, Option, Activity [Table Text Block]

	Three Months Ended December 31,
	201 9					201 8
	Number Of Shares			Weighted Average Exercise Price		Number of Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		722,567		$	8.18		728,867		$	8.17
Options forfeited/cancelled		(52,400	)		8.07		(334	)		7.93
Outstanding options at the end of period		670,167		$	8.19		728,533		$	8.17
Exercisable options at the end of period		670,167		$	8.19		728,533		$	8.17

Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

				Options Outstanding						Options Exercisable
Range of Exercise Price				Number of Shares Outstanding		Weighted Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number of Shares Exercisable		Weighted Average Exercise Price
	$5.7501	-	$8.6250		560,667		2.7		7.96		560,667		7.96
	$8.6251	-	$11.5000		109,500		3.1		9.37		109,500		9.37
					670,167		2.7	$	8.19		670,167	$	8.19

XML

Note 16 - Related Party Transactions

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]

Note

1

6

– Related Party Transactions

The Company utilizes the services of a consultant in conjunction with its international operations. The consultant is the spouse of

one

of the owners of Serlefin Peru. For the

three

months ended

December 31, 2019

and

2018,

the Company paid this consultant

$12,500

and

$25,239,

respectively. The Company does

not

have a formal agreement in place for these services, and the Company had

no

amounts due to this consultant as of

December 31, 2019

and

September 30, 2019.

On

August 15, 2019,

the Company and Lou Piccolo, a non-independent member of the Company’s Board of Directors, entered into a new

one

-year,

$30,000

contract, pursuant to which Mr. Piccolo will provide consulting services. The compensation is to be paid quarterly. The Company recorded an expense of

$7,500

for the

three

months ended

December 31, 2019.

There were

no

amounts due to Mr. Piccolo at

December 31, 2019

and

September 30, 2019.

XML

Note 12 - Net Income Per Share

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Earnings Per Share [Text Block]

Note

1

2

-Net Income per Share

Basic per share data is determined by dividing net income (loss) by the weighted average shares outstanding during the period. Diluted per share data is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. The assumed proceeds from the exercise of dilutive options are calculated using the treasury stock method based on the average market price for the period.  

The following table presents the computation of basic and diluted per share data for the

three

months ended

December 31, 2019

and

2018:

	For the Three Months Ended December 31, 2019		For the Three Months Ended December 31, 2018
Net Income	$	1,045,000	$	1,275,000
Basic earnings per common share	$	0.16	$	0.19
Diluted earnings per common share	$	0.16	$	0.19
Weighted average number of common shares outstanding:
Basic		6,567,765		6,685,415
Dilutive effect of stock options		68,333		307
Diluted		6,636,098		6,685,722

At

December 31, 2019

there were

85,000

stock options outstanding that could have an effect on the future computation of dilution per common share, had their effect

not

been anti-dilutive.

XML

Note 3 - Consumer Receivables Acquired for Liquidation (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Consumer Receivables after Liquidation [Table Text Block]

	For the Three Months Ended December 31,
	201 9			201 8
Balance, beginning of period	$	1,668,000		$	3,749,000
Net cash collections		(3,375,000	)		(4,025,000	)
Impairment		(23,000	)		–
Effect of foreign currency translation		46,000			(147,000	)
Finance income recognized		3,132,000			3,494,000
Balance, end of period	$	1,448,000		$	3,071,000
Finance income as a percentage of collections		92.8	%		86.8	%

Schedule of Collections on Gross Basis [Table Text Block]

	For the Three Months Ended December 31,
	201 9		201 8
Gross collections (1)	$	6,549,000	$	8,220,000
Commissions and fees (2)		3,174,000		4,195,000
Net collections	$	3,375,000	$	4,025,000

XML

Note 7 - Right of Use Assets and Liabilities (Details Textual) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Oct. 01, 2019	Sep. 30, 2019
Operating Lease, Liability, Total	$ 540,000
Operating Lease, Right-of-Use Asset	$ 545,000
Operating Lease, Weighted Average Discount Rate, Percent	3.50%		3.50%
Operating Lease, Expense	$ 100,000	$ 100,000
Accounting Standards Update 2016-02 [Member]
Operating Lease, Liability, Total			$ 636,000
Operating Lease, Right-of-Use Asset			$ 636,000

XML

Note 2 - Investments in Debt and Equity Securities - Investments Classified as Available-for-sale (Details) - USD ($)	Dec. 31, 2019	Sep. 30, 2019	[1]
Amortized Cost	$ 60,418,000	$ 55,946,000
Unrealized Gains	170,000	178,000
Unrealized Losses	1,000	1,000
Debt Securities, Available-for-sale, Total	$ 60,587,000	$ 56,123,000

[1] At September 30, 2018, the Company reported investments in equity securities and available for sale debt securities as a single line item on the Company's condensed consolidated balance sheet. With the Company's adoption of ASU No. 2016-01 on October 1, 2018, the Company has included the current breakout above for comparability purposes only.

XML

Note 4 - Equity Method Investments (Details Textual) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019
Equity Method Investments	$ 278,000		$ 280,000
Income (Loss) from Equity Method Investments, Total	$ (4,000)	$ (30,000)
Serlefin BPO&O Peru S.A.C. [Member]
Equity Method Investment, Ownership Percentage	80.00%
Equity Method Investment, Ownership Percentage, Controlled Party	20.00%
Noninterest Expense Related to Performance Fees	$ 300,000	$ 300,000
Equity Method Investments	278,000		$ 280,000
Income (Loss) from Equity Method Investments, Total	$ 256,000
Serlefin BPO&O Peru S.A.C. [Member]
Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest	49.00%
Three Individuals [Member]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	51.00%

XML

Document And Entity Information - shares	3 Months Ended
	Dec. 31, 2019	Feb. 18, 2020
Document Information [Line Items]
Entity Registrant Name	ASTA FUNDING INC
Entity Central Index Key	0001001258
Trading Symbol	asfi
Current Fiscal Year End Date	--09-30
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		6,567,765
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Title of 12(b) Security	Common Stock, par value $.01 per share

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Comprehensive income is as follows:
Net income	$ 1,045,000	$ 1,275,000
Net unrealized (loss) gain on debt securities, net of tax benefit / (expense) of $50,000 and ($52,000) during the three months ended December 31, 2019 and 2018, respectively.	(128,000)	135,000
Reclassification adjustment for securities sold, net of tax expense of $48,000 and $0 during the three months ended December 31, 2019 and 2018, respectively.	122,000
Foreign currency translation, net of tax benefit / (expense) of $13,000 and ($25,000) during the three months ended December 31, 2019 and 2018, respectively.	(44,000)	80,000
Other comprehensive (loss) income	(50,000)	215,000
Total comprehensive income	$ 995,000	$ 1,490,000

XML

Note 17 - Segment Reporting (Details Textual)	3 Months Ended
	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)
Number of Reportable Segments	3
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	$ 1,448,000	$ 1,668,000
Colombia and Peru [Member]
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	$ 1,200,000

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net income	$ 1,045,000	$ 1,275,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	24,000	16,000
Deferred income taxes	176,000	162,000
Impairment of consumer receivables acquired for liquidation	23,000
Stock based compensation		7,000
Unrealized gain on equity securities	(10,000)	29,000
Provision/ (recoveries) for bad debts - personal injury claims	(302,000)	203,000
Loss from equity method investment	4,000	30,000
Changes in:
Prepaid and income taxes receivable	196,000	414,000
Due from third party collection agencies and attorneys	191,000	64,000
Accounts receivable	63,000	(203,000)
Other assets	156,000	184,000
Other liabilities	43,000	(232,000)
Right of use assets	91,000
Right of use liabilities	(96,000)
Income taxes payable	203,000
Net cash provided by operating activities	1,807,000	1,949,000
Cash flows from investing activities:
Principal collected on receivables acquired for liquidation	242,000	535,000
Purchase of available for sale debt securities and investments in equity securities	(48,172,000)	(25,920,000)
Proceeds from sale of available for sale debt securities	43,612,000	20,574,000
Proceeds from note receivable		482,000
Proceeds from settlement receivable	463,000	473,000
Personal injury claims - advances	(49,000)
Personal injury claims - receipts	1,008,000	1,729,000
Change in equity method investment	(2,000)	(61,000)
Net cash used in investing activities	(2,898,000)	(2,188,000)
Cash flows from financing activities:
Net cash provided by financing activities
Foreign currency effect on cash	(61,000)	166,000
Net decrease in cash and cash equivalents	(1,152,000)	(73,000)
Cash and cash equivalents at beginning of period	4,308,000	6,284,000
Cash and cash equivalents at end of period	3,156,000	6,211,000
Supplemental disclosure of non-cash operating activities:
Initial recognition of right of use assets	636,000
Initial recognition of lease liabilities	$ 636,000

XML

Note 2 - Investments in Debt and Equity Securities (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Gain (Loss) on Securities [Table Text Block]

	Three Months Ended December 31, 2019		Three Months Ended December 31, 2018
Net gains and (losses) recognized during the period on equity securities	$	10,000	$	(29,000	)
Less: Net gains and (losses) recognized during the period on equity securities sold during the period		–		–
Unrealized gains and (losses) recognized during the reporting period on equity securities still held at the reporting date	$	10,000	$	(29,000	)

Available-for-sale Securities [Table Text Block]

December 31, 2019	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Available for sale debt securities	$	60,418,000	$	170,000	$	1,000	$	60,587,000

September 30, 2019	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Available for sale debt securities	$	55,946,000	$	178,000	$	1,000	$	56,123,000

XML

Note 15 - Fair Value of Financial Measurements and Disclosures

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Fair Value Disclosures [Text Block]

Note

1

5

-Fair Value of Financial Measurements and Disclosures

 

Fair Value of Financial Instruments

 

The estimated fair value of the Company’s financial instruments is summarized as follows:

	December 31, 201 9				September 30, 201 9
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Cash equivalents (Level 1)	$	66,000	$	66,000	$	64,000	$	64,000
Investments in equity securities (Level 1)		8,234,000		8,234,000		8,136,000		8,136,000
Available-for-sale debt securities (Level 2)		60,587,000		60,587,000		56,123,000		56,123,000
Consumer receivables acquired for liquidation (Level 3)		1,448,000		26,221,000		1,668,000		25,783,000

Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments:

Cash equivalents - The Company considers all highly liquid debt instruments purchased with an original maturity of

three

months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value. 

Investments in equity securities - The investments in equity consist of mutual funds that are valued based on quoted prices in active markets. 

Available-for-sale debt securities - The available-for-sale debt securities consist of U.S. Treasury Bills that are valued based on quoted prices in active markets. The U.S. Treasury Bills have been classified as available for sale by the Company, as they are deemed to be short term investments, and can be liquidated as needed by the Company. 

The Company’s investments in equity securities and available-for-sale debt securities are classified as Level

1

and Level

2

financial instruments, respectively, based on the classifications described above. The Company did

not

have any transfers into (out of) Level

1

investments during the fiscal year ended

September 30, 2018.

The Company had

no

Level

3

available-for-sale investments during the

three

months ended

December 

31,

2019.

 

Consumer receivables acquired for liquidation - The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of monthly collections for consumer receivables over the estimated collection period, which is currently

January

of

2020

through

December

of

2026.

These cash flows are then fair valued using a discount rate of

20%.

See Note

3

for the rollforward of Level

3

activity.

XML

Note 11 - Income Taxes

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Income Tax Disclosure [Text Block]

 

Note

1

1

-Income Taxes

 

 At the end of each interim reporting period, the Company estimates its effective income tax rate expected to be applicable for the full year. The estimate is used in providing for income taxes on a year-to-date basis and

may

change in subsequent interim periods. The Company’s effective tax rate from operations for the

three

months ended

December 31, 2019

was

27.3%,

compared to

27.9%

in the same period of the prior year. The effective rate for fiscal

2020

and

2019

differed from the U.S. federal statutory rate of

21%,

primarily due to state income taxes and other permanent differences. 

 The Company files income tax returns in the U.S federal jurisdiction, various state jurisdictions, and various foreign countries. The Company does

not

have any uncertain tax positions.

XML

Note 3 - Consumer Receivables Acquired for Liquidation (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Dec. 31, 2007	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019
Face Value of Charged-off Consumer Receivables		$ 0	$ 0
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		$ 1,448,000		$ 1,668,000
Foreign Consumer Receivables, Percentage of Total Consumer Receivable		83.10%		83.80%
Percentage of Assets Related to Internationl Operation		1.30%		1.50%
Percentage of Revenue Related to International Operation		6.20%	4.90%
Fee Charged on Portfolio Purchase	3.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Consumer Portfolio 1 [Member]
Concentration Risk, Percentage		25.20%		23.90%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Consumer Portfolio 2 [Member]
Concentration Risk, Percentage		16.90%		16.20%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Consumer Portfolio 3 [Member]
Concentration Risk, Percentage		14.50%		14.10%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Consumer Portfolio 4 [Member]
Concentration Risk, Percentage		10.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Receivable Portfolio 4 [Member]
Concentration Risk, Percentage				11.00%
Supplier Concentration Risk [Member] | Consumer Receivable Portfolio [Member] | Five Collection Organizations [Member]
Concentration Risk, Percentage		27.00%		28.00%
Supplier Concentration Risk [Member] | Consumer Receivable Portfolio at All Third Party Collection Agencies and Attorneys [Member] | Five Collection Organizations [Member]
Concentration Risk, Percentage		86.00%		86.00%
PERU
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		$ 900,000		$ 1,100,000
COLOMBIA
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		300,000		300,000
Non-US [Member]
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		$ 1,200,000		$ 1,400,000

XML

Note 5 - Personal Injury Claims Funding (Details Textual) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019
Personal Injury Claims Income	$ 376,000	$ 713,000
Personal Injury Claims, Net Reserve	1,100,000		$ 1,200,000
Simia Capital LLC [Member]
Personal Injury Claims Assets	1,100,000		1,300,000
Personal Injury Claims Income	16,000	15,000
Sylvave, LLC [Member]
Personal Injury Claims Assets	3,100,000	3,700,000
Personal Injury Claims Income	346,000	699,000
Arthur Funding [Member]
Personal Injury Claims Assets	300,000		$ 200,000
Personal Injury Claims Income	$ 14,000	$ 0

XML

Note 7 - Right of Use Assets and Liabilities - Additional Information About Operating Leases (Details)	Dec. 31, 2019	Oct. 01, 2019
Weighted average remaining lease term (in years) (Year)	2 years 146 days
Weighted average discount rate	3.50%	3.50%

XML

Note 16 - Related Party Transactions (Details Textual) - USD ($)		3 Months Ended
	Aug. 15, 2019	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019
Consultant [Member]
Related Party Transaction, Expenses from Transactions with Related Party		$ 12,500	$ 25,239
Due to Related Parties, Total		0		$ 0
Director [Member]
Related Party Transaction, Expenses from Transactions with Related Party		7,500
Due to Related Parties, Total		$ 0		$ 0
Consultant Contract Value	$ 30,000

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals)	Dec. 31, 2018 USD ($)
Accounting Standards Update 2014-09 [Member]
Cumulative effect adjustment for adoption of new accounting principle, tax	$ 80,000
Accounting Standards Update 2016-01 [Member]
Cumulative effect adjustment for adoption of new accounting principle, tax	5,000
Cumulative effect adjustment for adoption of new accounting principle, tax	$ 5,000

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenues:
Revenues	$ 4,316,000	$ 5,468,000
Other Income:
Interest and dividend income	329,000	199,000
Other income, net	11,000	35,000
Total other income	340,000	234,000
	4,656,000	5,702,000
Expenses:
General and administrative	3,192,000	3,926,000
Impairment of consumer receivables acquired for liquidation	23,000
Loss from equity method investment	4,000	30,000
	3,219,000	3,956,000
Income before income tax	1,437,000	1,746,000
Income tax expense	392,000	471,000
Net income	$ 1,045,000	$ 1,275,000
Net income per share:
Basic (in dollars per share)	$ 0.16	$ 0.19
Diluted (in dollars per share)	$ 0.16	$ 0.19
Weighted average number of common shares outstanding:
Basic (in shares)	6,567,765	6,685,415
Diluted (in shares)	6,636,098	6,685,722
Finance Income, Net [Member]
Revenues:
Revenues	$ 3,132,000	$ 3,494,000
Personal Injury Claims Income [Member]
Revenues:
Revenues	376,000	713,000
Disability Fee Income [Member]
Revenues:
Revenues	$ 808,000	$ 1,261,000

XML

Note 13 - Stock Option Plans - Summary of Outstanding Options (Details) - $ / shares	3 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018
Options Outstanding, Number of Shares Outstanding (in shares)	670,167	722,567	728,533	728,867
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	2 years 255 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 8.19	$ 8.18	$ 8.17	$ 8.17
Options Exercisable, Number of Shares Exercisable (in shares)	670,167		728,533
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 8.19		$ 8.17
Range One [Member]
Range of Exercise Price, Lower (in dollars per share)	5.7501
Range of Exercise Price, Upper (in dollars per share)	$ 8.625
Options Outstanding, Number of Shares Outstanding (in shares)	560,667
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	2 years 255 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 7.96
Options Exercisable, Number of Shares Exercisable (in shares)	560,667
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 7.96
Range Two [Member]
Range of Exercise Price, Lower (in dollars per share)	8.6251
Range of Exercise Price, Upper (in dollars per share)	$ 11.50
Options Outstanding, Number of Shares Outstanding (in shares)	109,500
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	3 years 36 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 9.37
Options Exercisable, Number of Shares Exercisable (in shares)	109,500
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 9.37

XML

Note 12 - Net Income Per Share (Details Textual) - shares	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Incremental Common Shares Attributable to Share-based Payment Arrangements, Total	68,333	307
Share-based Payment Arrangement, Option [Member]
Incremental Common Shares Attributable to Share-based Payment Arrangements, Total	85,000

XML

Note 7 - Right of Use Assets and Liabilities - Future Minimum Payments (Details) - USD ($)	Dec. 31, 2019	Sep. 30, 2019
2020	$ 247,000
2021	122,000
2022	131,000
2023	65,000
Thereafter
Total lease payments	565,000
Less interest	(25,000)
Operating Lease, Liability, Total	$ 540,000

XML

Note 7 - Right of Use Assets and Liabilities

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

Note

7

– Right of Use Assets

and Liabilities

Effective

October 1, 

2019,

the Company adopted ASU

2016

-

02,

and all subsequent ASUs that modified Topic

842.

For the Company, Topic

842

affected the accounting treatment for operating lease agreements in which the Company is the lessee by recognizing lease assets and liabilities on the balance sheet. The Company leases the premises for

two

New Jersey office facilities under operating lease agreements expiring in various years through

2023.

The Company is responsible to pay all insurance, utilities, maintenance and repairs on the office spaces. All of the Company’s leases are classified as operating leases.

On

October 1, 2019,

the Company recorded additional lease liabilities of approximately

$636,000

attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately

$636,000.

The Company used

3.5%

as its incremental borrowing rate to calculate the net present value of its leases on

October 1, 2019.

As of

December 31, 2019,

the Company’s operating lease right-of-use assets and operating lease liabilities were approximately

$545,000

and

$540,000,

respectively.

The Company leases office space in Englewood Cliffs, New Jersey and subleases office space in Fort Lee, New Jersey under agreements classified as operating leases.

The lease agreement in Englewood Cliffs, New Jersey expires on

August 31, 2020

and does

not

include any renewal option. The lease agreement provides for an initial monthly base amount plus annual escalations through the term of the lease.

The sublease agreement in Fort Lee, New Jersey expires on

March 31, 2023

and does

not

include any renewal option. The lease agreement provides for an initial monthly base amount plus certain additional amounts pursuant to the leasing arrangement between the landlord and sublessor.

In adopting the new accounting guidance, the Company used the following practical expedients for transitional relief as provided for in ASU

2018

-

01:

●An entity need

not

reassess whether any expired or existing contracts are or contain leases.

●An entity need

not

reassess the lease classification for any expired or existing leases.

●An entity need

not

reassess initial direct costs for any existing leases.

●An entity

may

elect to apply hindsight to leases that existed during the period from the beginning of the earliest period presented in the financial statements until the effective date.

The Company also elected

not

to include short-term leases (i.e., leases with initial terms of

twelve

months or less) or insignificant equipment leases on the condensed consolidated balance sheet as provided for in the accounting guidance.

The following provides additional information about the Company’s operating leases:

As of

December 31, 

2019:

Weighted average remaining lease term (in years)	2.40
Weighted average discount rate	3.5	%

As of

December 31, 

2019,

the future minimum payments for the fiscal years are as follows:

2020	$	247,000
2021		122,000
2022		131,000
2023		65,000
Thereafter		–
Total lease payments		565,000
Less interest		(25,000	)
Operating lease liability	$	540,000

The Company leases its facilities in (i) Englewood Cliffs, New Jersey, and (ii) Fort Lee, New Jersey. Rent expense for the

three

months ended

December 31, 2019

and

2018

was

$0.1

million and

$0.1

million, respectively.

XML

Note 3 - Consumer Receivables Acquired for Liquidation

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

Note

3

-

Consumer

Receivables Acquired for Liquidation

Accounts acquired for liquidation are stated at cost and consist primarily of defaulted consumer loans of individuals throughout the United States and South America.

The following tables summarize the changes in the condensed consolidated balance sheet account of consumer receivables acquired for liquidation during the following periods:

	For the Three Months Ended December 31,
	201 9			201 8
Balance, beginning of period	$	1,668,000		$	3,749,000
Net cash collections		(3,375,000	)		(4,025,000	)
Impairment		(23,000	)		–
Effect of foreign currency translation		46,000			(147,000	)
Finance income recognized		3,132,000			3,494,000
Balance, end of period	$	1,448,000		$	3,071,000
Finance income as a percentage of collections		92.8	%		86.8	%

 During the

three

months ended

December 31, 2019

and

2018

the Company did

not

purchase any new portfolios.

As of

December 31, 2019,

the Company held consumer receivables acquired for liquidation from Peru and Colombia of

$0.9

million and

$0.3

million, respectively. The total amount of foreign consumer receivables acquired for liquidation was

$1.2

million, or

83.1%

of the

$1.4

million in total consumer receivables held at

December 31, 2019.

Of the total consumer receivables held domestically and internationally

4

individual portfolios comprise

25.2%,

16.9%,

14.5%

and

10.0%

of the overall asset balance at

December 31, 2019.

As of

September 30, 2019,

the Company held consumer receivables acquired for liquidation from Peru and Colombia of

$1.1

million and

$0.3

million, respectively. The total amount of foreign consumer receivables acquired for liquidation was

$1.4

million, or

83.8%

of the total consumer receivables held of

$1.7

million at

September 30, 2019.

Of the total consumer receivables held domestically and internationally

4

individual portfolios comprise

23.9%,

16.2%,

14.1%

and

11.0%

of the overall asset balance at

September 30, 2019.

As of

December 31, 2019,

and

September 30, 2019,

1.3%

and

1.5%

of the Company's total assets were related to its international operation, respectively. For the

three

months ended

December 31, 2019

and

2018,

6.2%

and

4.9%

of the Company's total revenue related to its international operations, respectively.

At

December 31, 2019,

approximately

27%

of the Company’s portfolio face value was serviced by

five

collection organizations.  At

September 

30,

2019,

approximately

28%

of the Company’s portfolio face value was serviced by

five

collection organizations. The Company has servicing agreements in place with these

five

collection organizations, as well as all of the Company’s other

third

-party collection agencies and attorneys that cover standard contingency fees and servicing of the accounts. While the

5

collection organizations represent only

27%

and

28%

as of

December 31, 2019

and

September 30, 2019,

respectively, of the Company’s portfolio face value, it does represent approximately

86%

and

86%

of the Company’s portfolio face value at all

third

party collection agencies and attorneys as of

December 31, 2019

and

September 30, 2019,

respectively.

The following table summarizes collections received by the Company’s

third

-party collection agencies and attorneys, less commissions and direct costs, for the

three

months ended

December 31, 2019

and

2018,

respectively. 

	For the Three Months Ended December 31,
	201 9		201 8
Gross collections (1)	$	6,549,000	$	8,220,000
Commissions and fees (2)		3,174,000		4,195,000
Net collections	$	3,375,000	$	4,025,000

( 1 )

Gross collections include collections from third  party collection agencies and attorneys, collections from in-house efforts and collections represented by account sales.

( 2 )

Commissions are earned by  third  party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also received a  3% fee on gross collections received by the Company in connection with the related portfolio purchase.  The fee is charged for asset location and skip tracing in connection with this portfolio purchase.

XML

Note 7 - Right of Use Assets and Liabilities (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Lease, Cost [Table Text Block]

Weighted average remaining lease term (in years)	2.40
Weighted average discount rate	3.5	%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

2020	$	247,000
2021		122,000
2022		131,000
2023		65,000
Thereafter		–
Total lease payments		565,000
Less interest		(25,000	)
Operating lease liability	$	540,000

XML

Note 15 - Fair Value of Financial Measurements and Disclosures (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]

	December 31, 201 9				September 30, 201 9
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Cash equivalents (Level 1)	$	66,000	$	66,000	$	64,000	$	64,000
Investments in equity securities (Level 1)		8,234,000		8,234,000		8,136,000		8,136,000
Available-for-sale debt securities (Level 2)		60,587,000		60,587,000		56,123,000		56,123,000
Consumer receivables acquired for liquidation (Level 3)		1,448,000		26,221,000		1,668,000		25,783,000

XML

Note 2 - Investments in Debt and Equity Securities - Net Gains and Losses Recognized in Equity Securities (Details) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Net gains and (losses) recognized during the period on equity securities	$ 10,000	$ (29,000)
Less: Net gains and (losses) recognized during the period on equity securities sold during the period
Unrealized gains and (losses) recognized during the reporting period on equity securities still held at the reporting date	$ 10,000	$ (29,000)

XML

Note 17 - Segment Reporting

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

1

7

-Seg

m

ent Reporting

The Company operates through strategic business units that are aggregated into

three

reportable segments: Consumer receivables, personal injury claims and social security disability advocacy. The

three

reportable segments consist of the following:

• Consumer R eceivables -  This segment is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including judgment receivables, charged off receivables and semi-performing receivables.  Judgment receivables are accounts where outside attorneys have secured judgments directly against the consumer. Primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of our distressed consumer receivables are MasterCard ®, Visa ® and other credit card accounts which were charged-off by the issuers or providers for non-payment. We acquire these and other consumer receivable portfolios at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. Recently, the Company's efforts have been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. The Company holds consumers receivable acquired for liquidation in both Colombia and Peru of approximately $1.2 million. The business conducts its activities primarily under the name Palisades Collection, LLC.

• Personal I njury C laims  - This segment is comprised of purchased interests in personal injury claims from claimants who are a party in personal injury litigation or claims. The Company advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Arthur Funding, on March 16, 2018 to continue in the personal injury claims funding business. Arthur Funding began funding advances on personal injury claims in May 2019. Arthur Funding, Simia and Sylvave conduct its businesses solely in the United States and obtains business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business is also obtained from its website and through attorneys. Simia and Sylvave are not funding any new advances, but continue to collect on outstanding personal injury claim advances in the ordinary course.

• Social Security B enefit A dvocacy -  GAR Disability and Five Star are advocacy groups representing individuals throughout the United States in their claims for social security disability and supplemental security income benefits from the Social Security and Veterans Administration.

Certain non-allocated administrative costs, interest income and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, investments in equity securities and available-for-sale debt securities, a note receivable, property and equipment, goodwill, deferred taxes and other assets. 

The following table shows results by reporting segment for the

three

months ended

December 31, 2019

and

2018:

(Dollars in millions)	Consumer Receivables		Social Security Disability Advocacy		Personal Injury Claims		Corporate ( 2 )			Total
Three Months Ended December 31,
2019:
Revenues	$	3.1	$	0.8	$	0.4	$	–		$	4.3
Other income		–		–		–		0.3			0.3
Segment profit (loss)		2.9		–		0.6		(2.1	)		1.4
Segment Assets (1)		7.2		1.0		4.8		79.5			92.5
2018:
Revenues	$	3.5	$	1.3	$	0.7	$	–		$	5.5
Other income		0.1		–		–		0.1			0.2
Segment profit (loss)		2.9		0.4		0.5		(2.1	)		1.7
Segment Assets (1)		12.0		1.4		10.1		62.6			86.1

The Company does

not

have any intersegment revenue transactions.

( 1 )	Includes other amounts in other line items on the condensed consolidated balance sheet.
( 2 )	Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.

XML

Note 13 - Stock Option Plans

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Stock Option Plans [Text Block]

Note

1

3

-Stock Option Plans

2012

Stock Option and Performance Award Plan

On

February 

7,

2012,

the Company adopted the

2012

Stock Option and Performance Award Plan (the

“2012

Plan”), which was approved by the stockholders of the Company on

March 

21,

2012.

The

2012

Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights, in addition to the granting of stock options.

The Company authorized

2,000,000

shares of Common Stock for issuance under the

2012

Plan. Under the

2012

Plan, the Company has granted options to purchase an aggregate of

540,800

shares, awarded

245,625

shares of restricted stock, and has cancelled

115,268

options, leaving

1,328,843

shares available as of

December 31, 2019.

At

December 31, 2019,

54

of the Company’s employees were able to participate in the

2012

Plan.

Equity Compensation Plan

On

December 

1,

2005,

the Company adopted the Equity Compensation Plan (the “Equity Compensation Plan”), which was approved by the stockholders of the Company on

March 

1,

2006.

The Equity Compensation Plan was adopted to supplement the Company’s

2002

Stock Option Plan (as defined below).

The Equity Compensation Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock options, stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights. 

The Company authorized

1,000,000

shares of Common Stock for issuance under the Equity Compensation Plan. As of

March 

21,

2012,

no

more awards could be issued under this plan.

2002

Stock Option Plan

  

On

March 

5,

2002,

the Company adopted the

2002

Stock Option Plan (the

“2002

Plan”), which was approved by the stockholders of the Company on

May 

1,

2002.

The

2002

Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company. 

The

2002

Plan authorized the granting of incentive stock options (as defined in Section 

422

of the Internal Revenue Code of

1986,

as amended (the “Code”)) and non-qualified stock options to eligible employees of the Company, including officers and directors of the Company (whether or

not

employees) and consultants of the Company.  

The Company authorized

1,000,000

shares of Common Stock for issuance under the

2002

Plan. As of

March 

5,

2012,

no

more awards could be issued under this plan.

Summary of the Plans

 

Compensation expense for stock options and restricted stock is recognized over the requisite vesting or service period. Compensation expense for restricted stock is based upon the market price of the shares underlying the awards on the grant date. 

The following table summarizes stock option transactions under the

2012

Plan, the Equity Compensation Plan and the

2002

Plan (collectively, the “Plans”):

	Three Months Ended December 31,
	201 9					201 8
	Number Of Shares			Weighted Average Exercise Price		Number of Shares			Weighted Average Exercise Price
Outstanding options at the beginning of period		722,567		$	8.18		728,867		$	8.17
Options forfeited/cancelled		(52,400	)		8.07		(334	)		7.93
Outstanding options at the end of period		670,167		$	8.19		728,533		$	8.17
Exercisable options at the end of period		670,167		$	8.19		728,533		$	8.17

The following table summarizes information about the Plans outstanding options as of

December 31, 2019:

				Options Outstanding						Options Exercisable
Range of Exercise Price				Number of Shares Outstanding		Weighted Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number of Shares Exercisable		Weighted Average Exercise Price
	$5.7501	-	$8.6250		560,667		2.7		7.96		560,667		7.96
	$8.6251	-	$11.5000		109,500		3.1		9.37		109,500		9.37
					670,167		2.7	$	8.19		670,167	$	8.19

The Company recognized

$0

and

$7,000

of compensation expense related to the stock options vested during the

three

months ended

December 31, 2019

and

2018,

respectively. As of

December 31, 2019,

there was

no

unrecognized compensation cost related to stock option awards. 

The intrinsic value of the outstanding and exercisable options as of

December 31, 2019

was approximately

$1.4

million. The weighted average remaining contractual life of exercisable options is

2.7

years. There were

no

options exercised during the

three

months ended

December 31, 2019

and

2018.

The fair value of the stock options that vested during the

three

months ended

December 31, 2019

and

2018

was approximately

$0

and

$76,000,

respectively. There were

no

options granted during the

three

months ended

December 31, 2019

and

2018.

 

The Company did

not

grant any restricted stock awards during the

three

months ended

December 31, 2019

and

2018.

As of

December 31, 2019,

and

September 30, 2019,

there was

no

unrecognized compensation cost related to restricted stock awards. 

XML

Note 17 - Segment Reporting - Schedule of Segment Reporting (Details) - USD ($)		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018		Sep. 30, 2019
Revenues		$ 4,316,000	$ 5,468,000
Other income		340,000	234,000
Segment profit (loss)		1,400,000	1,700,000
Segment Assets (1)		92,509,000	86,100,000	[1]	$ 90,685,000
Operating Segments [Member] | Consumer Receivables [Member]
Revenues		3,100,000	3,500,000
Other income	[2]		100,000
Segment profit (loss)		2,900,000	2,900,000
Segment Assets (1)	[1]	7,200,000	12,000,000
Operating Segments [Member] | GAR Disability Advocates [Member]
Revenues		800,000	1,300,000
Other income	[2]
Segment profit (loss)			400,000
Segment Assets (1)	[1]	1,000,000	1,400,000
Operating Segments [Member] | Personal Injury Claims [Member]
Revenues	[3]	400,000	700,000
Other income	[2],[3]
Segment profit (loss)	[3]	600,000	500,000
Segment Assets (1)	[1],[3]	4,800,000	10,100,000
Corporate, Non-Segment [Member]
Revenues	[4]
Other income	[2],[4]	300,000	100,000
Segment profit (loss)	[4]	(2,100,000)	(2,100,000)
Segment Assets (1)	[1],[4]	$ 79,500,000	$ 62,600,000

[1] Includes other amounts in other line items on the consolidated balance sheet.

[2] Included in other income is approximately $0.6 million and $4.0 million in gain on settlements for the years ended September 30, 2019 and 2018, respectively (see Note 10 - Settlements).

[3] The Company recorded Pegasus as an equity investment in its consolidated financial statements through January 12, 2018. Commencing on January 13, 2018, Sylvave is consolidated in the Company's financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.

[4] Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.

XML

Note 15 - Fair Value of Financial Measurements and Disclosures (Details Textual)	Dec. 31, 2019
Measurement Input, Discount Rate [Member]
Consumer Receivables Acquired for Liquidation, Measurement Input	0.2

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2019	Sep. 30, 2019
ASSETS
Cash and cash equivalents	$ 3,156,000	$ 4,308,000
Available-for-sale debt securities (at fair value)	60,587,000	56,123,000	[1]
Investments in equity securities (at fair value)	8,234,000	8,136,000
Consumer receivables acquired for liquidation (at cost)	1,448,000	1,668,000
Investment in personal injury claims, net	4,533,000	5,190,000
Due from third party collection agencies and attorneys	421,000	596,000
Accounts receivable, net	203,000	266,000
Prepaid and income taxes receivable, net	68,000	264,000
Furniture and equipment, net of accumulated depreciation of $1.9 million at December 31, 2019 and at September 30, 2019	96,000	120,000
Right of use assets	545,000
Equity method investment	278,000	280,000
Settlement receivable	1,095,000	1,558,000
Deferred income taxes	9,457,000	9,631,000
Goodwill	1,410,000	1,410,000
Other assets	978,000	1,135,000
Total assets	92,509,000	90,685,000
LIABILITIES
Accounts payable and accrued expenses	1,027,000	941,000
Right of use liability	540,000
Income taxes payable	778,000	575,000
	2,345,000	1,516,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock
Common stock, $.01 par value, authorized 30,000,000 shares; issued 13,459,708 at December 31, 2019 and September 30, 2019; and outstanding 6,567,765 at December 31, 2019 and September 30, 2019	135,000	135,000
Additional paid-in capital	68,558,000	68,558,000
Retained earnings	89,217,000	88,172,000
Accumulated other comprehensive income, net of taxes	226,000	276,000
Treasury stock (at cost) 6,891,943 shares at December 31, 2019 and September 30, 2019	(67,972,000)	(67,972,000)
Total stockholders’ equity	90,164,000	89,169,000
Total liabilities and stockholders’ equity	92,509,000	90,685,000
Series A Junior Participating Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Preferred stock

[1] At September 30, 2018, the Company reported investments in equity securities and available for sale debt securities as a single line item on the Company's condensed consolidated balance sheet. With the Company's adoption of ASU No. 2016-01 on October 1, 2018, the Company has included the current breakout above for comparability purposes only.

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (Parentheticals) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Unrealized gain (loss) on debt securities, tax	$ 50,000	$ (52,000)
Reclassification adjustment for securities sold, tax	48,000	0
Foreign currency translation, tax benefit (expense)	$ 13,000	$ (25,000)

XML

Note 3 - Consumer Receivables Acquired for Liquidation - Collections Received Less Commissions and Direct Costs (Details) - USD ($)		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Gross collections (1)	[1]	$ 6,549,000	$ 8,220,000
Commissions and fees (2)	[2]	3,174,000	4,195,000
Net collections		$ 3,375,000	$ 4,025,000

[1] Gross collections include collections from third party collection agencies and attorneys, collections from in-house efforts and collections represented by account sales.

[2] Commissions are earned by third party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also received a 3% fee on gross collections received by the Company in connection with the related portfolio purchase. The fee is charged for asset location and skip tracing in connection with this portfolio purchase.

XML

Note 6 - Non-recourse Debt (Details Textual) - USD ($)			1 Months Ended
	Jun. 03, 2014	Aug. 07, 2013	Jun. 30, 2016	Mar. 31, 2007	Dec. 31, 2019	Sep. 30, 2019
Portfolio Purchase				$ 300,000,000
Receivables Financing Agreement Term				3 years
Percentage of Ownership in Subsidiaries		100.00%
Prepayment Fees		$ 15,000,000
Receivable Finance Agreement, Portfolio Purchase Collections, Percentage		30.00%
Debt Instrument, Final Principal Payment	$ 2,900,000
Voluntary Debt Prepayment	1,900,000
Receivable Finance Agreement, Collections from Portfolio Purchase	$ 16,900,000		$ 16,900,000
Bank of Montreal [Member]
Non-Recourse Debt					$ 77,000	$ 22,000
Receivables Financing Agreement [Member]
Non-Recourse Debt				$ 227,000,000

XML

Note 13 - Stock Option Plans (Details Textual)	3 Months Ended		93 Months Ended
	Dec. 31, 2019 USD ($) shares	Dec. 31, 2018 USD ($) shares	Dec. 31, 2019 USD ($) shares	Sep. 30, 2019 USD ($)	Mar. 21, 2012 shares	Mar. 05, 2012 shares	Mar. 01, 2006 shares	May 01, 2002 shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0
Share-based Payment Arrangement, Expense | $	$ 0	$ 7,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $	0		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $	$ 1,400,000		1,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	2 years 255 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $	$ 0	$ 76,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	0	0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $	$ 0		$ 0	$ 0
The 2012 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized					2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			540,800
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period	115,268
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,328,843		1,328,843
Share-based Compensation Arrangement by Share-based Payment Award, Number of Eligible Employees	54		54
The 2012 Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			245,625
Equity Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized							1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					0
The 2002 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized								1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						0

XML

Note 9 - Interest Dividend and Other Income - Summary of Other Income (Details) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Interest and dividend income	$ 329,000	$ 199,000
Realized gain		25,000
Unrealized gain (loss)	10,000	(29,000)
Other	1,000	39,000
	$ 340,000	$ 234,000

XML

Note 12 - Net Income Per Share (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	For the Three Months Ended December 31, 2019		For the Three Months Ended December 31, 2018
Net Income	$	1,045,000	$	1,275,000
Basic earnings per common share	$	0.16	$	0.19
Diluted earnings per common share	$	0.16	$	0.19
Weighted average number of common shares outstanding:
Basic		6,567,765		6,685,415
Dilutive effect of stock options		68,333		307
Diluted		6,636,098		6,685,722

XML

Note 1 - Business and Basis of Presentation (Details Textual)	3 Months Ended
	Dec. 31, 2019 USD ($)	Oct. 01, 2019 USD ($)	Sep. 30, 2019 USD ($)
Number of Reportable Segments	3
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 3,156,000		$ 4,308,000
Debt, Current, Total	0	$ 0
Stockholders' Equity Attributable to Parent, Ending Balance	90,200,000
Cash, Uninsured Amount, Foreign	2,000,000
Operating Lease, Liability, Total	540,000
Operating Lease, Right-of-Use Asset	$ 545,000
Operating Lease, Weighted Average Discount Rate, Percent	3.50%	3.50%
Accounting Standards Update 2016-02 [Member]
Operating Lease, Liability, Total		$ 636,000
Operating Lease, Right-of-Use Asset		$ 636,000
Fair Value, Inputs, Level 1 [Member]
Available-for-sale Securities, Total	$ 68,800,000

XML

Note 5 - Personal Injury Claims Funding

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Personal Injury Claims [Text Block]

Note

5

-

Personal Injury Claims Funding

Simia and Sylvave

As of

December 31, 2019,

Simia had a personal injury claims portfolio of

$1.1

million, and recognized revenue for the

three

months then ended of

$16,000.

  As of

September 30, 2019,

Simia had a personal injury claims portfolio of

$1.3

million, and recognized revenue of

$15,000

for the

three

months ended

December 31, 2018.  

 As of

December 31, 2019,

Sylvave had a personal injury claims portfolio of

$3.1

million, and recognized revenue for the

three

months then ended of

$346,000.

 As of

September 30, 2019,

Sylvave had a personal injury claims portfolio of

$3.7

million, and recognized revenue of

$699,000

for the

three

months ended

December 31, 2018. 

Simia and Sylvave remain in operation to continue to collect on their outstanding personal injury claim portfolios, but will

not

be funding any new advances to claimants.

Arthur

Funding

Arthur Funding began funding advances on personal injury claims in

May 2019.

As of

December 31, 2019,

Arthur Funding had a personal injury claims portfolio of

$0.3

million, and recognized revenue for the

three

months then ended of

$14,000.

As of

September 30, 2019,

Arthur Funding had a personal injury claims portfolio of

$0.2

million, and

no

revenue was recognized for the

three

months ended

December 31, 2018.  

The following tables summarize the changes in the balance sheet account of personal injury claim portfolios held by Simia, Sylvave and Arthur Funding, net of reserves, for the following periods: 

	December 31, 2019			December 31, 2018
Balance, beginning of period	$	5,190,000		$	10,745,000
Personal claim advances		49,000			–
(Write offs) recoveries		302,000			(203,000	)
Personal injury claims income		376,000			713,000
Personal injury claims receipts		(1,384,000	)		(2,442,000	)
Balance, end of period	$	4,533,000		$	8,813,000

 The Company recognized personal injury claims income of

$0.4

million and

$0.7

million for the

three

months ended

December 31, 2019

and

2018,

respectively. The Company has recorded a net reserve against its investment in personal injury claims of

$1.1

million as of

December 31, 2019

and

$1.2

million as of

September 30, 2019.

XML

Note 1 - Business and Basis of Presentation

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

Note

1

-Business and Basis of Presentation

Business

 

Asta Funding, Inc., a Delaware Corporation (the “Company,” “we” or “us”), together with its wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XXIII”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), EMIRIC, LLC (“EMIRIC”), Simia Capital, LLC (“Simia”), Sylvave, LLC (“Sylvave”) (formerly known as Pegasus Funding, LLC (“Pegasus”)), Arthur Funding LLC (“Arthur Funding”) (formerly known as Practical Funding, LLC (“Practical Funding”)), and other subsidiaries, which are

not

all wholly owned, is engaged in several business segments in the financial services industry including funding of personal injury claims, through the Company's wholly owned subsidiaries Sylvave, Simia and Arthur Funding, social security disability advocacy through the Company's wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables.

We operate principally in the United States in

three

reportable business segments: consumer receivables, social security disability advocacy and personal injury claims.

Consumer

R

eceivables

This segment is engaged in the business of purchasing, managing for its own account and servicing distressed charged off receivables including consumer receivables. Recently, our effort has been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. We acquire these consumer receivables at substantial discounts to their face values, based on the characteristics of the underlying accounts of each portfolio. 

 

Personal

I

njury

C

laims

This segment is comprised of purchased interests in personal injury claims from claimants who are a party to a personal injury claim. The Company advances to each claimant funds on a non-recourse basis at an agreed upon fee, in anticipation of a future settlement. The Company capitalizes employee compensation and benefits expenses as direct costs related to the origination of personal injury advances. Claims purchased consist of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The Company historically funded personal injury claims in Simia and Sylvave. The Company formed a new wholly owned subsidiary, Practical Funding on

March 16, 2018

to continue in the personal injury claims funding business. On

April 8, 2019,

Practical Funding changed its name to Arthur Funding, LLC. Arthur Funding began funding advances on personal injury claims in

May 2019 (

see Note

5

).

Simia commenced operations in

January 2017,

and conducts its business solely in the United States. Simia obtained its business from external brokers and internal sales professionals soliciting attorneys and law firms who represent claimants who have personal injury claims. Business was also obtained from its website and through attorneys. The personal injury claims segment includes the consolidated results of operations of Sylvave, Simia and Arthur Funding. Simia and Sylvave are

not

funding any new advances, but continue to collect on outstanding personal claim advances in the ordinary course.

Social

S

ecurity

D

isability

A

dvocacy

 

This segment consists of advocacy groups representing individuals throughout the United States in their claims for social security disability and supplemental social security income benefits from the Social Security Administration and Department of Veterans Affairs. It relies upon Search Engine Optimization (“SEO”) to bring awareness to its intended market. 

Basis of Presentation

 

The condensed consolidated balance sheet as of

December 31, 2019,

the condensed consolidated statements of operations for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of comprehensive income (loss) for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of stockholders’ equity as of and for the

three

months ended

December 31, 2019,

and the condensed consolidated statements of cash flows for the

three

months ended

December 31, 2019

and

2018,

are unaudited. The

September 

30,

2019

financial information included in this report was derived from our audited financial statements included in our Annual Report on Form

10

-K for the fiscal year ended

September 30, 2019.

In the opinion of management, all adjustments necessary to present fairly our financial position at

December 31, 2019,

the results of operations for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of comprehensive income (loss) for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of stockholders' equity for the

three

months ended

December 31, 2019

and condensed consolidated statements of cash flows for the

three

months ended

December 31, 2019

and

2018

have been made. The results of operations for the

three

months ended

December 31, 2019

and

2018

are

not

necessarily indicative of the operating results for any other interim period or the full fiscal year. 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Rule

10

-

01

of Regulation S-

X

promulgated by the Securities and Exchange Commission and therefore do

not

include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form

10

-K for the fiscal year ended

September 30, 2019

filed with the Securities and Exchange Commission (the

“2019

Form

10

-K”).

The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and industry practices.

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

The condensed consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 

Liquidity

 At

December 31, 

2019

,

the Company had

$3.2

million in cash and cash equivalents, as well as

$68.8

million in Level

1

securities within the fair value hierarchy that are classified as available for sale debt securities and investments in equity securities, on hand and

no

debt.  In addition, the Company had

$90.2

 million in stockholders' equity at

December 31, 2019.

We believe that our available cash resources and expected cash inflows from operations will be sufficient to fund operations for at least the next

twelve

months.

Concentration of Credit Risk - Cash and

C

ash

E

quivalents

The Company considers all highly liquid investments with a maturity date of

three

months or less at the date of purchase to be cash equivalents.  

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company did

not

have cash balances withany domestic bank at

December

31

,

2019

that exceeded the balance insured by the FDIC limit. Two foreign banks with an aggregate

$2.0

million balances are

not

FDIC insured. The Company does

not

believe it is exposed to any significant credit risk due to concentration of cash.

Investments in Equity Securities

 

All equity investments in nonconsolidated entities are measured at fair value with changes recognized in earnings, except for those accounted for using the equity method of accounting. Changes in the fair value of equity securities are included in other income, net on the condensed consolidated statement of operations. 

Available-for-Sale Debt Securities

 

Debt investments that the Company intends to hold for an indefinite period of time, but

not

necessarily to maturity, are classified as available-for-sale debt securities and are carried at fair value. Unrealized gains and losses on available-for-sale debt securities are determined using the specific-identification method. Unrealized gains/losses are recorded in other comprehensive income (loss).

Declines in the fair value of individual available-for-sale debt securities below their respective costs that are other than temporary will result in write-downs of the individual securities to their fair value. Factors affecting the determination of whether an other-than-temporary impairment has occurred include: a downgrading of the security by a rating agency, a significant deterioration in the financial condition of the issuer, or that management would

not

have the ability to hold a security for a period of time sufficient to allow for any anticipated recovery in fair value. 

Personal Injury Claim Advances and Impairments

The Company accounts for its investments in personal injury claims at an agreed upon fee, in anticipation of a future settlement. Purchased personal injury claim advances consists of the right to receive from a claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or reward with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse. When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon fee, and, if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.

Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with

third

party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have

not

exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collections of the fee income. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection of its initially funded cases as well as its fee income. 

Income Recognition - Consumer Receivables

The Company accounts for certain of its investments in consumer receivables using the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”)

310,

Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC

310”

). Under the guidance of ASC

310,

static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method the Company concluded the cost recovery method is the appropriate accounting method under the circumstances.

Under the guidance of ASC

310,

the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are

not

added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method,

no

income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (

zero

carrying balance on the balance sheet) while still generating cash collections. At such time, all cash collections are recognized as revenue when received.

Impairments - Consumer Receivables

The Company accounts for its impairments in accordance with ASC

310,

which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC

310

is dependent on the Company having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event the Company cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected, ASC

310

permits the change to the cost recovery method. The Company will recognize income only after it has recovered its carrying value. 

If collection projections indicate the carrying value will

not

be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. The Company believes it has significant experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying customers. The Company invests in these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid so that it believes its estimated cash flow offers an adequate return on acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom the Company has limited experience, it has the added benefit of soliciting its

third

party collection agencies and attorneys for their input on liquidation rates and, at times, incorporates such input into the estimates it uses for its expected cash flows, and the Company’s ability to recover their cost basis. 

 

Income Recognition - Social Security Disability Advocacy

In accordance with FASB ASC

606,

Revenue from Contracts with Customers, the Company recognizes disability fee income for GAR Disability Advocates and Five Star when disability claimant’s cases close, when cash is received or when the Company receives a notice of award from the Social Security Administration (“SSA”) or the Department of Veterans Affairs that stipulates the amount of fee approved by the SSA to be paid to the Company. The Company establishes a reserve for the differentials in amounts awarded by the SSA compared to the actual amounts received by the Company. Fees paid to the Company are withheld by the SSA against the claimant's disability claim award, and are remitted directly to the Company from the SSA.

Commissions and fees

  

Commissions and fees are the contractual commissions earned by

third

party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs and asset searches. The Company utilizes

third

party collection agencies and attorney networks.

Income taxes

  

Deferred federal and state taxes arise from (i) recognition of finance income collected for tax purposes, but

not

yet recognized for financial reporting; (ii) provision for impairments/credit losses, all resulting in timing differences between financial accounting and tax reporting; (iii) amortization of intangibles resulting in timing differences between financial accounting and tax reporting; (iv) stock based compensation; and (v) partnership investments.

Fair Value Hierarchy

 

FASB ASC

825,

Financial Instruments, (“ASC

825”

), requires disclosure of fair value information about financial instruments, whether or

not

recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

The Company records its available-for-sale debt securities and investments in equity securities at estimated fair value on a recurring basis. The accompanying condensed consolidated financial statements include estimated fair value information regarding its available-for-sale debt securities and investments in equity securities as of

December 31, 2019,

as required by FASB ASC

820,

Fair Value Measurements and Disclosures (“ASC

820”

). ASC

820

defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC

820

also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement. 

Level

1

- Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date.

Level

2

- Observable inputs other than Level

1

prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are

not

active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level

3

- Unobservable inputs that are supported by little or

no

market activity and significant to the fair value of the assets or liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use.

ASC

825

requires disclosure of fair value information about financial instruments, whether or

not

recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

Reclassification

  

Certain prior period amounts in the accompanying condensed consolidated financial statements have been reclassified in connection with the immaterial error correction (included in Note

1

of our

2019

Form

10

-K) to conform to the current year presentation.

Recent Accounting Pronouncements

 

Adopted During

the

Three Months Ended

December 31,

201

9

In

February 2016,

the FASB issued ASU

2016

-

02,

Leases (Topic

842

) (“ASU

2016

-

02”

) which requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet for all leases with terms longer than

12

months. For a lease with a term of

12

months or less, a lessee is permitted to make an accounting policy election by class of underlying asset

not

to recognize a right-of-use asset and lease liability. Additionally, when measuring assets and liabilities arising from a lease, optional payments should be included only if the lessee is reasonably certain to exercise an option to extend the lease, exercise a purchase option or

not

exercise an option to terminate the lease. In

January 2018,

the FASB issued ASU

2018

-

01,

Leases (Topic

842

): Land Easement Practical Expedient for Transition to Topic

842

(“ASU

2018

-

01”

). ASU

2018

-

01

was issued to address concerns about the cost and complexity of complying with the transition provisions of ASU

2016

-

02.

Additionally, in

July 2018,

the FASB issued ASU

No.

2018

-

11,

“Leases (Topic

842

): Targeted Improvements, which provides an alternative transition method that permits an entity to use the effective date of ASU

2016

-

02

as the date of initial application through the recognition of a cumulative effect adjustment to the opening balance of retained earnings upon adoption. The standard became effective in for fiscal years beginning after

December 15, 2018

and interim periods within those years, and early adoption is permitted (see Note

7

– Right of Use Assets). 

The Company adopted the lease accounting standard using the modified retrospective transition option on adoption on

October 1, 2019,

which had an immaterial impact to the Company’s condensed consolidated balance sheet. Upon adoption, the Company recorded additional lease liabilities of approximately

$636,000

attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately

$636,000.

The Company used

3.5%

as its incremental borrowing rate to calculate the net present value of its leases at

October 1, 2019,

based on the Company's estimated borrowing rate for a collateralized loan. The Company had

no

debt outstanding as of

October 1, 2019.

In

February 2018,

the FASB issued ASU

2018

-

02,

Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted on

December 22, 2017,

and requires certain disclosures about stranded tax effects. ASU

2018

-

02

was effective for the Company's fiscal year beginning

October 1, 2019,

with early adoption permitted, and were applied in the period of adoption in which the effect of the change in the U.S. federal corporate income tax rate in the Act was recognized. The adoption of this accounting update did

not

have a material impact on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements

Not

Yet Adopted

In

June 2016,

the FASB issued ASU

2016

-

13,

Financial Instruments-Credit Losses (Topic

326

): Measurement of Credit Losses on Financial Instruments. The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For the Company, this update will be effective for interim periods and annual periods beginning after

December 15, 2022.

Upon adoption, the Company will accelerate the recording of its credit losses and is continuing to assess the impact on its consolidated financial statements. 

In

January 2017,

the FASB issued ASU

2017

-

04

Intangibles - Goodwill and Other (Topic

350

): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step

2

from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after

December 15, 2019,

and interim periods within those fiscal years. The Company does

not

believe this update will have a material impact on its consolidated financial statements.

In

August 2018,

the FASB issued ASU

No.

2018

-

13,

Fair Value Measurement (Topic

820

): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements. The ASU removes the requirement to disclose: the amount of and reasons for transfers between Level

1

and Level

2

of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level

3

fair value measurements. The ASU requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level

3

fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level

3

fair value measurements. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after

December 15, 2019.

The Company is currently evaluating the impact this guidance will have on its consolidated financial statements.

 In

December 2019,

the FASB issued ASU

2019

-

12,

 Income Taxes (Topic

740

): Simplifying the Accounting for Income Taxes,which is intended to simplify various aspects related to accounting for income taxes. ASU

2019

-

12

removes certain exceptions to the general principles in Topic

740

and also clarifies and amends existing guidance to improve consistent application. ASU

2019

-

12

is effective for the Company beginning in fiscal

2022.

The Company is evaluating the impact of the adoption of ASU

2019

-

12

on its financial statements, but does

not

expect such adoption to have a material impact.

XML

Note 9 - Interest Dividend and Other Income

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Other Nonoperating Income and Expense [Text Block]

Note

9

– Interest

,

Dividend and Other Income

The following tables summarize interest, dividend and other income for the 

three

months ended

December 31, 2019

and

2018:

	December 31,
	2019		2018
Interest and dividend income	$	329,000	$	199,000
Realized gain		–		25,000
Unrealized gain (loss)		10,000		(29,000	)
Other		1,000		39,000
	$	340,000	$	234,000

XML

Note 13 - Stock Option Plans - Summary of Stock Option Plans (Details) - $ / shares	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Outstanding options at the beginning of period (in shares)	722,567	728,867
Outstanding options at the beginning of period (in dollars per share)	$ 8.18	$ 8.17
Options forfeited/cancelled, shares (in shares)	(52,400)	(334)
Options forfeited/cancelled (in dollars per share)	$ 8.07	$ 7.93
Outstanding options at the end of period (in shares)	670,167	728,533
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 8.18	$ 8.17	$ 8.19	$ 8.17
Options Exercisable, Number of Shares Exercisable (in shares)			670,167	728,533
Exercisable options at the end of period (in dollars per share)	$ 8.19	$ 8.17

XML

Note 11 - Income Taxes (Details Textual)	3 Months Ended	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Percent, Total	27.30%	27.90%

XML

Note 9 - Interest Dividend and Other Income (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Other Nonoperating Income (Expense) [Table Text Block]

	December 31,
	2019		2018
Interest and dividend income	$	329,000	$	199,000
Realized gain		–		25,000
Unrealized gain (loss)		10,000		(29,000	)
Other		1,000		39,000
	$	340,000	$	234,000

XML

Note 17 - Segment Reporting (Tables)

3 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

(Dollars in millions)	Consumer Receivables		Social Security Disability Advocacy		Personal Injury Claims		Corporate ( 2 )			Total
Three Months Ended December 31,
2019:
Revenues	$	3.1	$	0.8	$	0.4	$	–		$	4.3
Other income		–		–		–		0.3			0.3
Segment profit (loss)		2.9		–		0.6		(2.1	)		1.4
Segment Assets (1)		7.2		1.0		4.8		79.5			92.5
2018:
Revenues	$	3.5	$	1.3	$	0.7	$	–		$	5.5
Other income		0.1		–		–		0.1			0.2
Segment profit (loss)		2.9		0.4		0.5		(2.1	)		1.7
Segment Assets (1)		12.0		1.4		10.1		62.6			86.1

XML

Note 10 - Commitments and Contingencies

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

Note

10

-

Commitments and Contingencies

Legal Matters

 

On

November 7, 2019,

a shareholder of the Company filed a verified shareholder derivative complaint in the Court of Chancery of the State of Delaware against certain current and former officers and directors of the Company, and named the Company as a nominal defendant, alleging that certain actions taken by management constituted a violation of fiduciary duty to the Company. The Company believes the lawsuit is without merit and intends to vigorously defend the matter. On or about

January 8, 2020,

a motion to dismiss the complaint was filed on behalf of all individual defendants and the Company as nominal defendant. 

In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using our network of

third

-party law firms, against consumers. Also, consumers occasionally initiate litigation against us, in which they allege that we have violated a federal or state law in the process of collecting their account. We do

not

believe that these ordinary course matters are material to our business and financial condition. The Company is

not

involved in any other material litigation in which we are a defendant. 

XML

Note 6 - Non-recourse Debt

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Debt Disclosure [Text Block]

Note

6

-Non-Recourse Debt

Non-Recourse Debt -Bank of Montreal (“BMO”)

In

March 2007,

Palisades XVI borrowed approximately

$227

 million under a Receivables Financing Agreement, as amended in

July 2007, 

December 2007, 

May 2008, 

February 2009,

October 2010

and

August 2013 (

the “RFA”) from BMO, in order to finance the Portfolio Purchase which had a purchase price of

$300

million. The original term of the agreement was

three

years. This term was extended by each of the Second, Third, Fourth and Fifth Amendments and the most recent agreement signed in

August 2013. 

On

August 

7,

2013,

Palisades XVI, a

100%

owned bankruptcy remote subsidiary, entered into a Settlement Agreement and Omnibus Amendment (the “BMO Settlement Agreement”) with BMO as an amendment to the RFA. In consideration for a

$15

million prepayment funded by the Company, BMO agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO receives the next

$15

million of collections from the Portfolio Purchase or from voluntary prepayments by the Company, less certain credits for payments made prior to the consummation of the BMO Settlement Agreement (the “Remaining Amount”), Palisades XVI and its affiliates would be automatically released from liability in connection with the RFA (subject to customary exceptions). A condition on the release was Palisades XVI’s agreement to grant BMO, as of the time of the payment of the Remaining Amount, the right to receive

30%

of net collections from the Portfolio Purchase once Palisades XVI has received from future net collections, the sum of

$15

million plus voluntary prepayments included in the payment of the Remaining Amount (the “Income Interest”). On

June 

3,

2014,

Palisades XVI paid the Remaining Amount. The final principal payment of

$2.9

million included a voluntary prepayment of

$1.9

million provided from funds of the Company. Accordingly, Palisades XVI was entitled to receive

$16.9

million of future collections from the Portfolio Purchase before BMO would be entitled to receive any payments with respect to its Income Interest.

During the month of

June 2016,

the Company received the balance of the

$16.9

million and, as of

December 31, 2019

and

September 30, 2019,

the Company recorded a liability to BMO of approximately

$77,000

and

$22,000,

respectively, which has been recorded in accounts payable and accrued expenses on the Company’s consolidated balance sheet. The funds were subsequently remitted to BMO on

January 10, 2020

and

October 10, 2019,

respectively. The liability to BMO is recorded when actual collections are received. 

XML

Note 2 - Investments in Debt and Equity Securities

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Note

2

-Investments in Debt and Equity Securities

Investments in Equity Securities

Investments of equity securities at

December 31, 2019

and

September 30, 2019,

consists of mutual funds valued at

$8.2

million and

$8.1

million, respectively.

Net gains and losses recognized on investments in equity securities for the

three

months ended

December 31, 2019

and

2018

are as follows:

	Three Months Ended December 31, 2019		Three Months Ended December 31, 2018
Net gains and (losses) recognized during the period on equity securities	$	10,000	$	(29,000	)
Less: Net gains and (losses) recognized during the period on equity securities sold during the period		–		–
Unrealized gains and (losses) recognized during the reporting period on equity securities still held at the reporting date	$	10,000	$	(29,000	)

Available for Sale Debt Securities

Available for sale debt securities at

December 31, 2019

and

September 

30,

2019,

consist of the following:

December 31, 2019	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Available for sale debt securities	$	60,418,000	$	170,000	$	1,000	$	60,587,000

At

December 31, 2018,

the Company had

$35.8

million in U.S. Treasury Bills, classified as available-for-sale debt securities on the Company's condensed consolidated balance sheet.  These U.S. Treasury bills had

$135,000

(net of tax expense of

$52,000

) in unrealized gains that were recorded in other comprehensive income for the

three

months ended

December 31, 2018.

September 30, 2019	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Available for sale debt securities	$	55,946,000	$	178,000	$	1,000	$	56,123,000

Note

2

-Investments in Debt and Equity Securities (Continued)

Unrealized holding gains and losses on available for sale debt securities are included in other comprehensive income (loss) within stockholders’ equity. Realized gains (losses) on available for sale debt securities are included in other income (loss) and, when applicable, are reported as a reclassification adjustment in other comprehensive income (loss).  

XML

Significant Accounting Policies (Policies)

3 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

 

The condensed consolidated balance sheet as of

December 31, 2019,

the condensed consolidated statements of operations for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of comprehensive income (loss) for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of stockholders’ equity as of and for the

three

months ended

December 31, 2019,

and the condensed consolidated statements of cash flows for the

three

months ended

December 31, 2019

and

2018,

are unaudited. The

September 

30,

2019

financial information included in this report was derived from our audited financial statements included in our Annual Report on Form

10

-K for the fiscal year ended

September 30, 2019.

In the opinion of management, all adjustments necessary to present fairly our financial position at

December 31, 2019,

the results of operations for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of comprehensive income (loss) for the

three

months ended

December 31, 2019

and

2018,

the condensed consolidated statements of stockholders' equity for the

three

months ended

December 31, 2019

and condensed consolidated statements of cash flows for the

three

months ended

December 31, 2019

and

2018

have been made. The results of operations for the

three

months ended

December 31, 2019

and

2018

are

not

necessarily indicative of the operating results for any other interim period or the full fiscal year. 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Rule

10

-

01

of Regulation S-

X

promulgated by the Securities and Exchange Commission and therefore do

not

include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form

10

-K for the fiscal year ended

September 30, 2019

filed with the Securities and Exchange Commission (the

“2019

Form

10

-K”).

The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and industry practices.

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

The condensed consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Liquidity Disclosure [Policy Text Block]

Liquidity

 At

December 31, 

2019

,

the Company had

$3.2

million in cash and cash equivalents, as well as

$68.8

million in Level

1

securities within the fair value hierarchy that are classified as available for sale debt securities and investments in equity securities, on hand and

no

debt.  In addition, the Company had

$90.2

 million in stockholders' equity at

December 31, 2019.

We believe that our available cash resources and expected cash inflows from operations will be sufficient to fund operations for at least the next

twelve

months.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentration of Credit Risk - Cash and

C

ash

E

quivalents

The Company considers all highly liquid investments with a maturity date of

three

months or less at the date of purchase to be cash equivalents.  

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company did

not

have cash balances withany domestic bank at

December

31

,

2019

that exceeded the balance insured by the FDIC limit. Two foreign banks with an aggregate

$2.0

million balances are

not

FDIC insured. The Company does

not

believe it is exposed to any significant credit risk due to concentration of cash.

Equity Securities with Readily Determinable Fair Value [Policy Text Block]

Investments in Equity Securities

 

All equity investments in nonconsolidated entities are measured at fair value with changes recognized in earnings, except for those accounted for using the equity method of accounting. Changes in the fair value of equity securities are included in other income, net on the condensed consolidated statement of operations. 

Debt Securities, Available-for-sale [Policy Text Block]

Available-for-Sale Debt Securities

 

Debt investments that the Company intends to hold for an indefinite period of time, but

not

necessarily to maturity, are classified as available-for-sale debt securities and are carried at fair value. Unrealized gains and losses on available-for-sale debt securities are determined using the specific-identification method. Unrealized gains/losses are recorded in other comprehensive income (loss).

Declines in the fair value of individual available-for-sale debt securities below their respective costs that are other than temporary will result in write-downs of the individual securities to their fair value. Factors affecting the determination of whether an other-than-temporary impairment has occurred include: a downgrading of the security by a rating agency, a significant deterioration in the financial condition of the issuer, or that management would

not

have the ability to hold a security for a period of time sufficient to allow for any anticipated recovery in fair value. 

Personal Injury Claim Advances [Policy Text Block]

Personal Injury Claim Advances and Impairments

The Company accounts for its investments in personal injury claims at an agreed upon fee, in anticipation of a future settlement. Purchased personal injury claim advances consists of the right to receive from a claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or reward with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse. When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon fee, and, if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.

Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with

third

party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have

not

exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collections of the fee income. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection of its initially funded cases as well as its fee income. 

Income Recognition Impairments and Accretable Yield Adjustments [Policy Text Block]

Income Recognition - Consumer Receivables

The Company accounts for certain of its investments in consumer receivables using the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”)

310,

Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC

310”

). Under the guidance of ASC

310,

static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method the Company concluded the cost recovery method is the appropriate accounting method under the circumstances.

Under the guidance of ASC

310,

the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are

not

added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method,

no

income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (

zero

carrying balance on the balance sheet) while still generating cash collections. At such time, all cash collections are recognized as revenue when received.

Impairments - Consumer Receivables

The Company accounts for its impairments in accordance with ASC

310,

which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC

310

is dependent on the Company having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event the Company cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected, ASC

310

permits the change to the cost recovery method. The Company will recognize income only after it has recovered its carrying value. 

If collection projections indicate the carrying value will

not

be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. The Company believes it has significant experience in acquiring certain distressed consumer receivable portfolios at a significant discount to the amount actually owed by underlying customers. The Company invests in these portfolios only after both qualitative and quantitative analyses of the underlying receivables are performed and a calculated purchase price is paid so that it believes its estimated cash flow offers an adequate return on acquisition costs after servicing expenses. Additionally, when considering larger portfolio purchases of accounts, or portfolios from issuers with whom the Company has limited experience, it has the added benefit of soliciting its

third

party collection agencies and attorneys for their input on liquidation rates and, at times, incorporates such input into the estimates it uses for its expected cash flows, and the Company’s ability to recover their cost basis. 

 

Income Recognition - Social Security Disability Advocacy

In accordance with FASB ASC

606,

Revenue from Contracts with Customers, the Company recognizes disability fee income for GAR Disability Advocates and Five Star when disability claimant’s cases close, when cash is received or when the Company receives a notice of award from the Social Security Administration (“SSA”) or the Department of Veterans Affairs that stipulates the amount of fee approved by the SSA to be paid to the Company. The Company establishes a reserve for the differentials in amounts awarded by the SSA compared to the actual amounts received by the Company. Fees paid to the Company are withheld by the SSA against the claimant's disability claim award, and are remitted directly to the Company from the SSA.

Commissions, Policy [Policy Text Block]

Commissions and fees

  

Commissions and fees are the contractual commissions earned by

third

party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs and asset searches. The Company utilizes

third

party collection agencies and attorney networks.

Income Tax, Policy [Policy Text Block]

Income taxes

  

Deferred federal and state taxes arise from (i) recognition of finance income collected for tax purposes, but

not

yet recognized for financial reporting; (ii) provision for impairments/credit losses, all resulting in timing differences between financial accounting and tax reporting; (iii) amortization of intangibles resulting in timing differences between financial accounting and tax reporting; (iv) stock based compensation; and (v) partnership investments.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value Hierarchy

 

FASB ASC

825,

Financial Instruments, (“ASC

825”

), requires disclosure of fair value information about financial instruments, whether or

not

recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

The Company records its available-for-sale debt securities and investments in equity securities at estimated fair value on a recurring basis. The accompanying condensed consolidated financial statements include estimated fair value information regarding its available-for-sale debt securities and investments in equity securities as of

December 31, 2019,

as required by FASB ASC

820,

Fair Value Measurements and Disclosures (“ASC

820”

). ASC

820

defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC

820

also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement. 

Level

1

- Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date.

Level

2

- Observable inputs other than Level

1

prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are

not

active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level

3

- Unobservable inputs that are supported by little or

no

market activity and significant to the fair value of the assets or liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use.

ASC

825

requires disclosure of fair value information about financial instruments, whether or

not

recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates.

Reclassification, Policy [Policy Text Block]

Reclassification

  

Certain prior period amounts in the accompanying condensed consolidated financial statements have been reclassified in connection with the immaterial error correction (included in Note

1

of our

2019

Form

10

-K) to conform to the current year presentation.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

 

Adopted During

the

Three Months Ended

December 31,

201

9

In

February 2016,

the FASB issued ASU

2016

-

02,

Leases (Topic

842

) (“ASU

2016

-

02”

) which requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet for all leases with terms longer than

12

months. For a lease with a term of

12

months or less, a lessee is permitted to make an accounting policy election by class of underlying asset

not

to recognize a right-of-use asset and lease liability. Additionally, when measuring assets and liabilities arising from a lease, optional payments should be included only if the lessee is reasonably certain to exercise an option to extend the lease, exercise a purchase option or

not

exercise an option to terminate the lease. In

January 2018,

the FASB issued ASU

2018

-

01,

Leases (Topic

842

): Land Easement Practical Expedient for Transition to Topic

842

(“ASU

2018

-

01”

). ASU

2018

-

01

was issued to address concerns about the cost and complexity of complying with the transition provisions of ASU

2016

-

02.

Additionally, in

July 2018,

the FASB issued ASU

No.

2018

-

11,

“Leases (Topic

842

): Targeted Improvements, which provides an alternative transition method that permits an entity to use the effective date of ASU

2016

-

02

as the date of initial application through the recognition of a cumulative effect adjustment to the opening balance of retained earnings upon adoption. The standard became effective in for fiscal years beginning after

December 15, 2018

and interim periods within those years, and early adoption is permitted (see Note

7

– Right of Use Assets). 

The Company adopted the lease accounting standard using the modified retrospective transition option on adoption on

October 1, 2019,

which had an immaterial impact to the Company’s condensed consolidated balance sheet. Upon adoption, the Company recorded additional lease liabilities of approximately

$636,000

attributable to the Company’s operating leases based on the present value of the remaining minimum lease payments with an increase to right-of-use assets of approximately

$636,000.

The Company used

3.5%

as its incremental borrowing rate to calculate the net present value of its leases at

October 1, 2019,

based on the Company's estimated borrowing rate for a collateralized loan. The Company had

no

debt outstanding as of

October 1, 2019.

In

February 2018,

the FASB issued ASU

2018

-

02,

Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted on

December 22, 2017,

and requires certain disclosures about stranded tax effects. ASU

2018

-

02

was effective for the Company's fiscal year beginning

October 1, 2019,

with early adoption permitted, and were applied in the period of adoption in which the effect of the change in the U.S. federal corporate income tax rate in the Act was recognized. The adoption of this accounting update did

not

have a material impact on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements

Not

Yet Adopted

In

June 2016,

the FASB issued ASU

2016

-

13,

Financial Instruments-Credit Losses (Topic

326

): Measurement of Credit Losses on Financial Instruments. The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For the Company, this update will be effective for interim periods and annual periods beginning after

December 15, 2022.

Upon adoption, the Company will accelerate the recording of its credit losses and is continuing to assess the impact on its consolidated financial statements. 

In

January 2017,

the FASB issued ASU

2017

-

04

Intangibles - Goodwill and Other (Topic

350

): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step

2

from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after

December 15, 2019,

and interim periods within those fiscal years. The Company does

not

believe this update will have a material impact on its consolidated financial statements.

In

August 2018,

the FASB issued ASU

No.

2018

-

13,

Fair Value Measurement (Topic

820

): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements. The ASU removes the requirement to disclose: the amount of and reasons for transfers between Level

1

and Level

2

of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level

3

fair value measurements. The ASU requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level

3

fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level

3

fair value measurements. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after

December 15, 2019.

The Company is currently evaluating the impact this guidance will have on its consolidated financial statements.

 In

December 2019,

the FASB issued ASU

2019

-

12,

 Income Taxes (Topic

740

): Simplifying the Accounting for Income Taxes,which is intended to simplify various aspects related to accounting for income taxes. ASU

2019

-

12

removes certain exceptions to the general principles in Topic

740

and also clarifies and amends existing guidance to improve consistent application. ASU

2019

-

12

is effective for the Company beginning in fiscal

2022.

The Company is evaluating the impact of the adoption of ASU

2019

-

12

on its financial statements, but does

not

expect such adoption to have a material impact.

XML

Note 14 - Stockholders' Equity

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

 

Note

1

4

-Stockholders’ Equity

 

 The Company has

5,000,000

authorized preferred shares with a par value of

$0.01

per share. The Company’s board of directors (the “Board of Directors”) is authorized to divide the authorized shares of Preferred Stock into

one

or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes.

There were

no

shares of preferred stock issued and outstanding as of

December 31, 2019

and

2018.

Dividends are declared at the discretion of the Board of Directors and depend upon the Company’s financial condition, operating results, capital requirements and other factors that the Board of Directors deems relevant. In addition, agreements with the Company’s lenders

may,

from time to time, restrict the ability to pay dividends. As of

December 31, 2019,

there were

no

such restrictions, as there were

no

lending agreements in place.

No

dividends were declared during fiscal year

2020.

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Dec. 31, 2019	Sep. 30, 2019
Furniture and equipment, accumulated depreciation	$ 1,900,000	$ 1,900,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	30,000,000	30,000,000
Common stock, issued (in shares)	13,459,708	13,459,708
Common stock, outstanding (in shares)	6,567,765	6,685,415
Treasury stock, shares (in shares)	6,891,943	6,891,943
Series A Junior Participating Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	30,000	30,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Total
Balance, September 30, 2019 (in shares) at Sep. 30, 2018	13,459,708
Balance at Sep. 30, 2018	$ 135,000	$ 68,551,000	$ 80,834,000	$ 35,000	$ (67,128,000)	$ 82,427,000
Net Income			1,275,000			1,275,000
Unrealized loss on debt securities, net				135,000		135,000
Amount reclassified from other comprehensive income
Foreign currency translation, net				80,000		80,000
Cumulative effect adjustment for adoption of new accounting principle (Accounting Standards Update 2014-09 [Member]) at Sep. 30, 2018			173,000			173,000
Cumulative effect adjustment for adoption of new accounting principle (Accounting Standards Update 2016-01 [Member]) at Sep. 30, 2018			(10,000)	10,000
Adjusted opening equity (in shares) at Sep. 30, 2018	13,459,708
Adjusted opening equity at Sep. 30, 2018	$ 135,000	68,551,000	80,997,000	45,000	(67,128,000)	82,600,000
Stock based compensation expense		7,000				7,000
Unrealized gain (loss) on debt securities, net				135,000		135,000
Balance (in shares) at Dec. 31, 2018	13,459,708
Balance at Dec. 31, 2018	$ 135,000	68,558,000	82,272,000	260,000	(67,128,000)	84,097,000
Balance, September 30, 2019 (in shares) at Sep. 30, 2019	13,459,708
Balance at Sep. 30, 2019	$ 135,000	68,558,000	88,172,000	276,000	(67,972,000)	89,169,000
Net Income			1,045,000			1,045,000
Unrealized loss on debt securities, net				(128,000)		(128,000)
Amount reclassified from other comprehensive income				122,000		122,000
Foreign currency translation, net				(44,000)		(44,000)
Unrealized gain (loss) on debt securities, net				(128,000)		(128,000)
Balance (in shares) at Dec. 31, 2019	13,459,708
Balance at Dec. 31, 2019	$ 135,000	$ 68,558,000	$ 89,217,000	$ 226,000	$ (67,972,000)	$ 90,164,000

XML

Note 15 - Fair Value of Financial Measurements and Disclosures - Fair Value of Financial Measurements (Details) - USD ($)	Dec. 31, 2019	Sep. 30, 2019
Investments in equity securities (Level 1)	$ 8,234,000	$ 8,136,000
Available-for-sale debt securities (Level 2)	60,587,000	56,123,000	[1]
Reported Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents (Level 1)	66,000	64,000
Investments in equity securities (Level 1)	8,234,000	8,136,000
Reported Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]
Available-for-sale debt securities (Level 2)	60,587,000	56,123,000
Reported Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Consumer receivables acquired for liquidation (Level 3)	1,448,000	1,668,000
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents (Level 1)	66,000	64,000
Investments in equity securities (Level 1)	8,234,000	8,136,000	[2]
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]
Available-for-sale debt securities (Level 2)	60,587,000	56,123,000	[2]
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Consumer receivables acquired for liquidation (Level 3)	$ 26,221,000	$ 25,783,000	[2]

[1] At September 30, 2018, the Company reported investments in equity securities and available for sale debt securities as a single line item on the Company's condensed consolidated balance sheet. With the Company's adoption of ASU No. 2016-01 on October 1, 2018, the Company has included the current breakout above for comparability purposes only.

[2] At September 30, 2018, the Company reported investments in equity securities and available-for-sale debt securities as a single line item on the Company's consolidated balance sheet. With the Company's adoption of ASU No. 2016-01 on October 1, 2018, the Company has included the current breakout above for comparability purposes only.

XML

Note 3 - Consumer Receivables Acquired for Liquidation - Changes in Balance Sheet Account of Consumer Receivables Acquired for Liquidation (Details) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Balance	$ 1,668,000	$ 3,749,000
Net cash collections	(3,375,000)	(4,025,000)
Impairment	(23,000)
Effect of foreign currency translation	46,000	(147,000)
Finance income recognized	3,132,000	3,494,000
Balance	$ 1,448,000	$ 3,071,000
Finance income as a percentage of collections	92.80%	86.80%

XML

Note 5 - Personal Injury Claims Funding - Personal Claims Funding (Details) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Balance, beginning of period	$ 5,190,000	$ 10,745,000
Personal claim advances	49,000
(Write offs) recoveries	302,000	(203,000)
Personal injury claims income	376,000	713,000
Personal injury claims receipts	(1,384,000)	(2,442,000)
Balance, end of period	$ 4,533,000	$ 8,813,000